
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Diverse functions of NLRP3 inflammasome in PANoptosis and diseases - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE533C648AF36123053C640020045819.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cddiscover">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365032/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cell Death Discovery">
<meta name="citation_title" content="Diverse functions of NLRP3 inflammasome in PANoptosis and diseases">
<meta name="citation_author" content="Yuanyuan Jiang">
<meta name="citation_author_institution" content="Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China">
<meta name="citation_author" content="Zhiyuan Qiang">
<meta name="citation_author_institution" content="School of Medicine Southeast University, Nanjing, Jiangsu China">
<meta name="citation_author" content="Yue Liu">
<meta name="citation_author_institution" content="Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China">
<meta name="citation_author" content="Liwei Zhu">
<meta name="citation_author_institution" content="Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China">
<meta name="citation_author" content="Long Xiao">
<meta name="citation_author_institution" content="Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China">
<meta name="citation_author" content="Zhenfang Du">
<meta name="citation_author_institution" content="Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China">
<meta name="citation_author" content="Rong Cai">
<meta name="citation_author_institution" content="Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China">
<meta name="citation_author" content="Sheng Qiang">
<meta name="citation_author_institution" content="Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="389">
<meta name="citation_doi" content="10.1038/s41420-025-02689-1">
<meta name="citation_pmid" content="40830103">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365032/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365032/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365032/pdf/41420_2025_Article_2689.pdf">
<meta name="description" content="NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) is a vital sensor of the innate immune system, capable of responding to various exogenous invading pathogens and endogenous cell injury. Once the danger signal is detected, NLRP3 ...">
<meta name="og:title" content="Diverse functions of NLRP3 inflammasome in PANoptosis and diseases">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) is a vital sensor of the innate immune system, capable of responding to various exogenous invading pathogens and endogenous cell injury. Once the danger signal is detected, NLRP3 ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365032/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12365032">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41420-025-02689-1"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41420_2025_Article_2689.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365032%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12365032/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12365032/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365032/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cddiscover.jpg" alt="Cell Death Discovery logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cell Death Discovery" title="Link to Cell Death Discovery" shape="default" href="http://www.nature.com/cddiscovery/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cell Death Discov</button></div>. 2025 Aug 19;11:389. doi: <a href="https://doi.org/10.1038/s41420-025-02689-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41420-025-02689-1</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cell%20Death%20Discov%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell%20Death%20Discov%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cell%20Death%20Discov%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cell%20Death%20Discov%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Diverse functions of NLRP3 inflammasome in PANoptosis and diseases</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yuanyuan Jiang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yuanyuan Jiang</span></h3>
<div class="p">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuanyuan Jiang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Zhiyuan Qiang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Zhiyuan Qiang</span></h3>
<div class="p">
<sup>2</sup>School of Medicine Southeast University, Nanjing, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhiyuan Qiang</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yue Liu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yue Liu</span></h3>
<div class="p">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yue Liu</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Liwei Zhu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Liwei Zhu</span></h3>
<div class="p">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Liwei Zhu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Long Xiao</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Long Xiao</span></h3>
<div class="p">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xiao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Long Xiao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Du%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Zhenfang Du</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Zhenfang Du</span></h3>
<div class="p">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Du%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhenfang Du</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cai%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Rong Cai</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Rong Cai</span></h3>
<div class="p">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cai%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rong Cai</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Sheng Qiang</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Sheng Qiang</span></h3>
<div class="p">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sheng Qiang</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu China </div>
<div id="Aff2">
<sup>2</sup>School of Medicine Southeast University, Nanjing, Jiangsu China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 15; Revised 2025 Jul 17; Accepted 2025 Aug 7; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12365032  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830103/" class="usa-link">40830103</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) is a vital sensor of the innate immune system, capable of responding to various exogenous invading pathogens and endogenous cell injury. Once the danger signal is detected, NLRP3 recruits downstream molecules to assemble into inflammasomes, which induce inflammatory cell death and trigger an inflammatory response. PANoptosis is a specific mode of inflammatory cell death that integrates the processes of pyroptosis, apoptosis, and necrosis. It is primarily driven by a multiprotein complex termed the PANoptosome. The NLRP3 inflammasome, an essential component of the PANoptosome, is implicated in the pathogenesis of several human disorders. Targeted inhibition of NLRP3 activation specifically has a notable impact on mitigating a variety of disease conditions. This review briefly describes how the NLRP3 inflammasome forms and is activated, outlines its multifaceted roles in disorders, and emphasizes the vital role of NLRP3 in PANoptosis. Additionally, we discuss the potential of NLRP3 as a target for the clinical management of associated diseases. Improved understanding of the NLRP3 inflammasome and its involvement in PANoptosis is crucial for guiding new treatment strategies.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Cell death and immune response, Inflammasome</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Facts</h2>
<ul class="list" style="list-style-type:disc">
<li><p id="Par3">The NLRP3 inflammasome participates in numerous inflammatory cell deaths.</p></li>
<li><p id="Par4">NLRP3 has an essential function in mediating PANoptosis, a unique form of cell death identified in recent years.</p></li>
<li><p id="Par5">NLRP3 inhibitors are highly effective in various human diseases.</p></li>
</ul></section><section id="Sec2"><h2 class="pmc_sec_title">Open Questions</h2>
<ul class="list" style="list-style-type:disc">
<li><p id="Par7">How exactly is the NLRP3 inflammasome activated at the molecular level?</p></li>
<li><p id="Par8">How is the NLRP3 inflammasome involved in mediating PANoptosis?</p></li>
<li><p id="Par9">How can safe and effective NLRP3 inhibitors be developed for treating diseases in humans?</p></li>
</ul></section><section id="Sec3"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par10">The innate immune system can initiate a swift immune response through different pattern recognition receptors (PRRs), which serve as the primary defense against pathogen invasion and homeostatic perturbations [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. NLRP3-mediated pathogenic mechanisms were first identified in cryopyrin-associated periodic syndrome (CAPS), a hereditary autoinflammatory condition transmitted through dominant inheritance patterns [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. These patients with <em>NLRP3</em> gain-of-function mutations usually present with clinical features of periodic fevers, arthritis, and urticaria [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Earlier studies focused on the link between NLRP3 and IL-1-mediated inflammation and revealed that NLRP3 contributes to the progression of autoinflammatory diseases [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. In parallel, it has been discovered that NLRP3, as a sensor, recruits the adapter protein ASC (apoptosis-associated speck-like protein containing a C-terminal caspase-recruitment domain) through the interaction of homologous amino-terminal pyrin domains (PYDs) after encountering various stimuli, including pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). The ASC speck functions as a platform for the recruitment of pro-caspase-1 through CARD-CARD domain binding, completing the formation of the NLRP3 inflammasome, which triggers caspase-1 to self-cleave and activate [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. The activated caspase-1 subsequently cleaves gasdermin D (GSDMD), generating N-terminal fragments that are inserted into the cell membrane, where they form channels for IL-1β and IL-18 cytokine release [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Not only is the NLRP3 inflammasome essential for mediating host innate immune defense mechanisms and maintaining homeostasis, but it can also contribute to immunopathology in some diseases such as CAPS, atherosclerosis, multiple sclerosis (MS), and cancers [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Therefore, NLRP3 is recognized as a next-generation candidate target for numerous immune disorders due to its less immunosuppressive impact compared to existing anti-IL-1 treatments.</p>
<p id="Par11">The process of cell death is acknowledged to be irreversible and serves both physiological and pathological functions. Generally, it leads to the termination of corresponding functions and can result in bodily impairment. Nevertheless, several physiological processes, including embryonic development and immune selection of B cells, require cell death to remove damaged or obsolete cells. Additionally, this process reduces the harmful spread by eliminating pathogen-infected cells [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. The cell death pathway can be classified into non-lytic (largely immunologically silent) and lytic (pro-inflammatory) types. Apoptosis, a non-lytic form, is distinguished by the generation of apoptotic bodies, cytoplasmic vacuolation, nuclear condensation, and cytoskeletal degradation [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. By contrast, some cell death occurs through the lytic pathway, which involves cell bursting and the secretion of cytoplasmic pro-inflammatory contents. Pyroptosis and necroptosis are currently two of the most widely and deeply studied lytic pathways [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. For a long period, apoptosis has been known as a highly coordinated and immunologically “silent” process of cell death. In contrast, pyroptosis and necroptosis are regarded as “alarms” that release pro-inflammatory signals, triggering an inflammatory response [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. These forms of cell death are collectively known as programmed cell death (PCD), which involves tightly regulated and complex molecular effector mechanisms [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Recently, a new cell death pattern known as PANoptosis has attracted significant interest from researchers. It is described as a lytic and inflammatory PCD pathway governed by PANoptosome complexes, which combine the essential characteristics of pyroptosis, apoptosis, and necrosis; however, it does not fit neatly into any of these categories [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. PANoptosis, a distinct type of inflammatory cell death, is reported to have a key function in various diseases, such as infections, inflammatory diseases, and tumors [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Recent studies reveal that NLRP3 is an important element in the assembly of the PANoptosome complex, which leads to PANoptosis [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Therefore, NLRP3 inflammasome-mediated excessive cell death may cause adverse inflammation and could be targeted for treating various diseases.</p>
<p id="Par12">This review provides an overview of the mechanisms that initiate and activate the NLRP3 inflammasome, as well as its inseparable relationship with PANoptosis. It summarizes the latest advancements in potential NLRP3 inhibitors, offering attractive prospects for treatment strategies of related diseases.</p></section><section id="Sec4"><h2 class="pmc_sec_title">NLRP3 inflammasome activation</h2>
<p id="Par13">Inflammasomes, which are polymeric cytoplasmic protein complexes, trigger inflammatory responses and generally consist of a sensor protein, the adapter ASC, and the effector pro-caspase-1. Many sensor proteins of inflammasomes need to be activated by specific pathogen signals, such as NLRC4, which is primarily stimulated by bacterial flagella or the Salmonella type III secretion system (T3SS) [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Uniquely, the NLRP3 inflammasome exhibits broad activation specificity, responding to diverse PAMPs and DAMPs, including viral RNAs, pore-forming toxins, extracellular ATP, and particulate matter [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Current research classifies the mechanisms by which the NLRP3 inflammasome is activated into three distinct pathways: canonical, non-canonical, and one-step activation (also referred to as alternative activation).</p>
<section id="Sec5"><h3 class="pmc_sec_title">Canonical activation</h3>
<section id="Sec6"><h4 class="pmc_sec_title">The priming step</h4>
<p id="Par14">Canonical NLRP3 inflammasome activation is thought to require sequential priming and activation steps due to insufficient baseline NLRP3 expression (Fig. <a href="#Fig1" class="usa-link">1</a>). In the priming process, PRRs such as nucleotide-binding oligomerization domain-containing protein 2 (NOD2), toll-like receptors (TLRs), TNF receptors (including TNFR1 and TNFR2), and cytokine receptors (IL-1R and TNFR) detect PAMPs and DAMPs. This recognition triggers the nuclear factor-κB (NF-κB) signaling pathway, which increases the transcription of NLRP3 and key inflammatory precursors, pro-IL-1β and pro-IL-18 [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. However, recent evidence has shown that the priming step also licenses NLRP3 inflammasome assembly and activation. While the exact processes behind priming and licensing remain elusive, it is widely believed that the priming step is necessary to sufficiently induce functional NLRP3. This induction is achieved by regulating NLRP3 post-translational modifications (PTMs), such as ubiquitination, acetylation, phosphorylation, and SUMOylation. These modifications are crucial for the NLRP3 inflammasome to be completely assembled and activated [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>].</p>
<figure class="fig xbox font-sm" id="Fig1"><h5 class="obj_head">Fig. 1. Mechanisms of canonical NLRP3 inflammasome activation.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365032_41420_2025_2689_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/741134497cd9/41420_2025_2689_Fig1_HTML.jpg" loading="lazy" id="d33e361" height="560" width="790" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Canonical NLRP3 inflammasome activation generally involves two steps: the priming (left) and the activation (right). Induction of the priming step by LPS or endogenous cytokines such as TNF and IL-1β through binding of membrane-bound pattern recognition receptors, leading to activation of the NF-κB pathway to upregulate pro-IL-1β and NLRP3 expression. The activation process involves multiple molecular and cellular events, including efflux of K<sup>+</sup> or Cl<sup>−</sup>, Ca2<sup>+</sup> mobilization, lysosomes destruction, mtROS production, and mtDNA release, and trans-Golgi dispersion, promoting the assembly and activation of NLRP3 inflammasomes. Subsequently, activated Caspase-1 induces the maturation of inflammatory factors IL-1β and IL-18, and cleaves GSDMD, releasing its N-terminal domain to form membrane pores.</p></figcaption></figure></section><section id="Sec7"><h4 class="pmc_sec_title">The activation step</h4>
<p id="Par15">The priming process of inflammasome activation is essential for the subsequent activation phase, which is generally triggered by the recognition of NLRP3 agonists and involves inflammasome assembly and complete activation (Fig. <a href="#Fig1" class="usa-link">1</a>). Compared to most PRRs, which typically exhibit specificity for limited PAMPs or DAMPs, NLRP3 demonstrates a broad responsiveness to diverse stimuli. In general, NLRP3 is triggered by microbial (e.g., bacterial, viral) infections, DAMP-mediated inflammation, and exposure to various environmental irritants. However, NLRP3 typically does not directly interact with these stimuli. Instead, these stimulating factors induce cellular stress responses, which are then sensed by NLRP3. It has been documented that NLRP3 can sense cellular stress through a variety of pathways, including the release of potassium (K<sup>+</sup>) and chloride ions (Cl<sup>−</sup>), the mobilization of calcium ions (Ca<sup>2+</sup>), destruction of lysosomes, the production of mitochondrial reactive oxygen species (mtROS), mtDNA release, and trans-Golgi dispersion. Additionally, NLRP3 can be activated through protein kinase R (PKR) and mitochondrial antiviral signaling protein (MAVS) signaling [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Although there is already a substantial amount of data describing the upstream signaling pathways contributing to NLRP3 inflammasome activation, these pathways frequently overlap and occasionally contradict one another.</p></section></section><section id="Sec8"><h3 class="pmc_sec_title">Non-canonical activation</h3>
<p id="Par16">Research indicates that Gram-negative bacteria are engulfed by phagocytic cells, which subsequently trigger the destruction of their bacterial walls, liberating lipopolysaccharide (LPS) and lipid A. LPS can specifically recognize and attach to the CARD domain of caspase-11 in mice or its human orthologs (caspase-4/5). This ligand-receptor interaction induces the oligomerization and self-cleavage of caspases, culminating in non-canonical NLRP3 inflammasome activation (Fig. <a href="#Fig2" class="usa-link">2</a>) [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Unlike canonical pathways, this activation mechanism bypasses the priming step due to constitutive expression of caspase-4 in human cells. Activated caspase-4/5/11 execute pyroptotic cell death via GSDMD cleavage, generating N-terminal fragments that perforate plasma membranes. Meanwhile, ATP release during this process mediates potassium efflux, which synergistically promotes canonical NLRP3 inflammasome signaling [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. While LPS remains the predominant activator, some activators from other sources have also been identified. For example, oxidized phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (oxPAPC) can interact with unique regions of murine caspase-11, distinct from those that bind to LPS, thereby activating non-canonical NLRP3 inflammasomes [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>].</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Mechanisms of non-canonical and alternative NLRP3 inflammasome activation.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365032_41420_2025_2689_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/68e2ee4a54be/41420_2025_2689_Fig2_HTML.jpg" loading="lazy" id="d33e417" height="560" width="790" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Non-canonical NLRP3 inflammasome activation(left) is induced by LPS released by gram-negative bacteria. After entering the cytoplasm, LPS directly induces human Caspase-4/5 or murine Caspase-11 to promote the cleavage of GSDMD. Moreover, this process is accompanied by K<sup>+</sup> efflux-mediated activation of the canonical NLRP3 inflammasome. The alternative pathway of activation is induced by LPS in human monocytes, which directly activates NLRP3 inflammasome through the TLR4-mediated RIPK1-FADD-Caspase 8 signaling pathway without requiring K<sup>+</sup> efflux or ASC speck formation.</p></figcaption></figure></section><section id="Sec9"><h3 class="pmc_sec_title">Alternative activation</h3>
<p id="Par17">Unlike the two previously described activation pathways, LPS stimulation in human monocytes can trigger a distinct NLRP3 inflammasome activation pattern without requiring a second activation signal. In this process, there is no need for K<sup>+</sup> efflux, which contrasts with the ATP-P2X7-dependent pathway, pore-forming toxins, and some particulate matter-induced NLRP3 inflammasome activation [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Mechanistically, this pathway activates NLRP3 inflammasomes through the TLR4-TRIF-FADD-caspase-8 signaling axis, independent of ASC speck formation and pyroptosome assembly [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. These distinguishing features have led to its classification as the alternative (or one-step) NLRP3 inflammasome pathway (Fig. <a href="#Fig2" class="usa-link">2</a>). In addition, in vitro models using murine dendritic cells exposed to LPS for an extended period demonstrated the capability to elicit NLRP3-dependent IL-1β secretion without relying on ATP-P2X7 signaling cascades [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>].</p></section></section><section id="Sec10"><h2 class="pmc_sec_title">NLRP3 inflammasome in human diseases</h2>
<p id="Par18">Given that NLRP3 is an important protein involved in cell death and drives the pathophysiological mechanisms of many diseases, it has attracted considerable attention recently. Here, we discuss the impact of NLRP3 on autoimmune diseases, metabolic disorders, neurological conditions, fibrosis, and tumors (Table <a href="#Tab1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Role of NLRP3 inflammasome in different diseases.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Diseases</th>
<th colspan="1" rowspan="1">Disease and pathologic feature</th>
<th colspan="1" rowspan="1">Role of NLRP3 inflammasome</th>
<th colspan="1" rowspan="1">Ref</th>
</tr></thead>
<tbody>
<tr><td colspan="4" rowspan="1">Autoimmune diseases</td></tr>
<tr>
<td colspan="1" rowspan="1">Systemic lupus erythematosus (SLE)</td>
<td colspan="1" rowspan="1">Systemic inflammation and dysfunction of multiple organs</td>
<td colspan="1" rowspan="1">Promoting the activation of B cells</td>
<td colspan="1" rowspan="1">[<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rheumatoid arthritis (RA)</td>
<td colspan="1" rowspan="1">Joint pain, swelling and bone destruction</td>
<td colspan="1" rowspan="1">Promoting the differentiation of proinflammatory T cells and inducing the activation of adaptive immune responses</td>
<td colspan="1" rowspan="1">[<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Systemic sclerosis (SSc)</td>
<td colspan="1" rowspan="1">Immune dysregulation, endothelial dysfunction and progressive fibrosis</td>
<td colspan="1" rowspan="1">Regulating the activation of macrophages, B cells, Th cells, fibroblasts, and endothelial cells</td>
<td colspan="1" rowspan="1">[<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]</td>
</tr>
<tr><td colspan="4" rowspan="1">Metabolic diseases</td></tr>
<tr>
<td colspan="1" rowspan="1">Obesity</td>
<td colspan="1" rowspan="1">Chronic low-grade systemic inflammation</td>
<td colspan="1" rowspan="1">Reducing glucose uptake in insulin-target tissues (such as muscle and adipose tissue)</td>
<td colspan="1" rowspan="1">[<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>–<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Type 2 diabetes mellitus (T2DM)</td>
<td colspan="1" rowspan="1">Hyperglycemia, hyperlipidemia and insulin resistance (IR)</td>
<td colspan="1" rowspan="1">Reducing glucose uptake in insulin-target tissues (such as muscle and adipose tissue)</td>
<td colspan="1" rowspan="1">[<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>–<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Atherosclerosis</td>
<td colspan="1" rowspan="1">Atherosclerotic plaque formation</td>
<td colspan="1" rowspan="1">Mediating monocyte/macrophage aggregation and the proliferation of vascular endothelial cells</td>
<td colspan="1" rowspan="1">[<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>, <a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]</td>
</tr>
<tr><td colspan="4" rowspan="1">Neurodegenerative diseases</td></tr>
<tr>
<td colspan="1" rowspan="1">Alzheimer’s disease (AD)</td>
<td colspan="1" rowspan="1">β-amyloid plaque deposition, neurofibrillary tangles (NFTs) formation and chronic neuroinflammation</td>
<td colspan="1" rowspan="1">Regulating the formation of β-amyloid protein and the pathological changes of tau protein, and inducing inflammatory response</td>
<td colspan="1" rowspan="1">[<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Parkinson’s disease (PD)</td>
<td colspan="1" rowspan="1">Loss of dopaminergic neurons in the substantia nigra and α-synuclein-containing Lewy bodies</td>
<td colspan="1" rowspan="1">Mediating neuroinflammation, dopamine neuron loss and neurodegeneration</td>
<td colspan="1" rowspan="1">[<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Multiple sclerosis (MS)</td>
<td colspan="1" rowspan="1">Oligodendrocyte loss and axons demyelination</td>
<td colspan="1" rowspan="1">Promoting the migration of CD4+ T cells, macrophages, and dendritic cells to the central nervous system (CNS)</td>
<td colspan="1" rowspan="1">[<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fibrotic diseases</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Various organs fibrosis</td>
<td colspan="1" rowspan="1">Excess extracellular matrix (ECM) accumulation and damage of parenchymal cells</td>
<td colspan="1" rowspan="1">Accelerating the expression of fibrosis-related proteins and the deposition of extracellular matrix (ECM); promoting epithelial-mesenchymal transformation (EMT)</td>
<td colspan="1" rowspan="1">[<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>, <a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cancer</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">/</td>
<td colspan="1" rowspan="1">Complex and context-dependent</td>
<td colspan="1" rowspan="1">[<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section id="Sec11"><h3 class="pmc_sec_title">Autoimmune diseases</h3>
<p id="Par19">The main effectors of NLRP3 inflammasome activation are IL-1β and IL-18, which mature through caspase-1 cleavage. These inflammatory factors have an essential function in regulating the body’s immune response by affecting different immune cells [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Autoimmune diseases are pathologically defined by the disruption of immune tolerance and excessive immune responses, leading to specific or multiple organ damage [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Systemic lupus erythematosus (SLE) is a widespread autoimmune disease that typically manifests as systemic inflammation and dysfunction of multiple organs [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Research has shown that, compared to other groups, SLE patients—particularly those with lupus nephritis (LN)—exhibit increased NLRP3 inflammasome activation because of significant gain-of-function mutations in the <em>NLRP3</em> gene [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Moreover, upregulation of NLRP3 and IL-1β expression has been consistently detected across diverse cell types in SLE patients, such as renal tubular epithelial cells, macrophages, and peripheral blood mononuclear cells (PBMCs) [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>–<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Several inflammatory factors related to NLRP3 inflammasome activation, especially TNF-α, are upregulated in SLE[<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. TNF-α is a molecule of great interest that mediates SLE development by stimulating B cells to produce antibodies[<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Rheumatoid arthritis (RA) exemplifies an autoimmune disorder, although its exact pathogenesis has not yet been elucidated. Clinically, RA is distinguished by joint pain, swelling, and bone destruction [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Investigations determined that NLRP3-mediated IL-1β/18 release has an active effect on RA pathogenesis [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Through IL-1β/18, NLRP3 in the synovium facilitates the differentiation of proinflammatory T cells and stimulates adaptive immune responses, further aggravating RA [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Systemic sclerosis (SSc) is a disease of the connective tissue with autoimmune origins, featuring immune dysregulation, vascular endothelial impairment, and progressive fibrosis. It is caused by genetic susceptibility and environmental triggers, particularly occupational hazards, viral infections, and chemical agents [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Endothelial injury initiates a cascade that releases ROS and inflammatory factors, which help activate NLRP3 inflammasomes [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Compared to healthy individuals, SSc patients show elevated expression of NLRP3 and downstream cytokines in skin tissue [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. NLRP3 inflammasomes may contribute to SSc pathogenesis by modulating the activation of macrophages, B cells, Th cells, fibroblasts, and endothelial cells [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>].</p></section><section id="Sec12"><h3 class="pmc_sec_title">Metabolic disorders</h3>
<p id="Par20">The mutual communication between immunological and metabolic systems is crucial for maintaining metabolic equilibrium. Dysregulated NLRP3 inflammasome activation leads to an imbalance between these systems and the release of inflammatory factors that mediate metabolic disorders, such as obesity [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>], type 2 diabetes mellitus (T2DM) [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>], and atherosclerosis [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>], through autocrine or paracrine mechanisms. Obesity, marked by chronic low-grade systemic inflammation due to the excessive accumulation of fat, is also a key pathological mechanism that induces insulin resistance (IR) and T2DM [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. T2DM has become one of the fastest-growing metabolic diseases in the world and is distinguished by hyperglycemia, hyperlipidemia, and IR. In an inflammatory environment, ectopic fat accumulation in the muscles and liver leads to IR and abnormal elevations of glucose levels in the blood [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Several studies have revealed that, compared to healthy individuals, the NLRP3 expression and its activated products, IL-1β/18, are upregulated in the visceral and subcutaneous adipose tissue of obese individuals [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>, <a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Additionally, the reduced levels of NLRP3 and IL-1β are related to improved insulin sensitivity brought about by caloric restriction and weight loss [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. NLRP3 activation mechanistically facilitates the secretion of downstream inflammatory factors, including IL-1β, leading to IR that ultimately impairs glucose uptake in insulin-targeted tissues, including muscle and adipose tissue. This reduction in glucose uptake participates in the progression of obesity and diabetes [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. A recent investigation highlighted the link between the NLRP3 inflammasome and diabetic angiopathy. Experimental data reveal that significant NLRP3 hyperactivation occurs in aortic tissues of T2DM murine models, while the absence or inhibition of NLRP3 effectively mitigates vascular aging triggered by T2DM [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Additionally, atherosclerosis, a chronic inflammatory disease, contributes to most cardiovascular diseases. Massive immune cell infiltration occurs in the arterial wall, along with lipid deposition and hyperproliferation of vascular wall cells, which are the main reasons for the formation of atherosclerotic plaque [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. In an earlier study, scientists found that mice with atherosclerosis induced by low-density lipoprotein receptor deficiency exhibited reduced atherosclerosis when there was a deficiency of NLRP3 inflammasome elements in their bone marrow cells [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. The NLRP3 inflammasome-activated products IL-1β and IL-18 mediate monocyte/macrophage aggregation and vascular endothelial cell expansion, both of which are important factors in atherosclerosis pathogenesis [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>].</p></section><section id="Sec13"><h3 class="pmc_sec_title">Neurodegenerative diseases</h3>
<p id="Par21">Increasing evidence indicates that NLRP3 is a pivotal pathogenic driver across multiple neurodegenerative diseases, with demonstrated involvement in Alzheimer’s disease (AD) [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>], Parkinson’s disease (PD) [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>], and MS [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. AD is an incurable and progressively worsening neurodegenerative disorder distinguished by the formation of β-amyloid plaques, the aggregation of hyperphosphorylated tau in neurofibrillary tangles (NFT), and chronic neuroinflammation [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Investigations illustrated that the NLRP3 inflammasome activation is linked to β-amyloid formation and pathological changes in tau protein, supporting the amyloid cascade hypothesis in AD [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. Furthermore, the NLRP3 inflammasome triggers caspase-1 stimulation and IL-1β maturation, leading to inflammatory events [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. Patients with PD usually exhibit signs of tremor, rigidity, and bradykinesia. The main pathological features include the depletion of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies containing α-synuclein [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. NLRP3, a central driving factor in neurodegenerative diseases, primarily facilitates the pathological advancement of PD through the assembly and activation of inflammasomes in microglia, thereby mediating neuroinflammation [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Yan et al. discovered that when the NLRP3 inflammasome is triggered in mouse microglia, it exacerbates dyskinesia and the loss of dopaminergic neurons in the brain. This effect can be counteracted by Parkin’s role in degrading NLRP3 through ubiquitination [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. In addition, another study found that the NLRP3 inflammasome is autonomously activated in dopamine neurons, leading to cell death, which is a key mechanism contributing to dopamine neuron loss and neurodegeneration in PD [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. MS is a neurodegenerative condition mediated by an autoimmune response that typically affects the central nervous system (CNS), with patients presenting with cognitive and motor dysfunction. The mechanism is primarily induced by the immune response of CD4 + T cells against myelin antigens, leading to several pathological alterations, such as oligodendrocyte loss and axonal demyelination [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. The NLRP3 inflammasome facilitates the migration of various immune cells, including CD4 + T cells, macrophages, and dendritic cells, into the CNS, and is considered a crucial nexus between innate and adaptive immunity during early MS pathogenesis [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>]. Furthermore, IL-1β released from NLRP3-mediated cell death is a risk factor that promotes susceptibility to MS and its progression, closely related to T cell differentiation [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>, <a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>].</p></section><section id="Sec14"><h3 class="pmc_sec_title">Fibrotic diseases</h3>
<p id="Par22">Fibrosis is a prevalent pathological consequence of chronic inflammation in several organs, marked by excessive deposition of extracellular matrix (ECM) and the injury or loss of parenchymal cells resulting from the inflammatory response [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. The NLRP3 inflammasome, a polyprotein oligomer integral to numerous inflammation-associated illnesses, contributes to the fibrosis of multiple organs, such as the hepatic, renal, cardiac, and pulmonary tissues [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>]. Generally, NLRP3 activation can accelerate the production and secretion of inflammatory mediators, trigger the activation of effector cells, and upregulate fibrotic protein expression, thereby exacerbating the deposition of ECM. Experimental evidence from murine hepatic fibrosis models demonstrates that NLRP3-mediated hepatic stellate cell activation promotes the development of liver fibrosis [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. Additionally, Kaufmann et al. discovered that NLRP3 activation was associated with macrophage recruitment and early liver fibrosis [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. It is worth noting that the NLRP3 inflammasome was significantly activated in the renal tissue of UUO mice and in those with streptozotocin-induced diabetes. Inhibition of NLRP3 activation significantly enhanced renal function and mitigated renal fibrosis [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>, <a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>], which is related to its influence on inflammatory factor production and podocyte activity [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. Similarly, NLRP3- knockout (NLRP3-KO) mice maintained on a high-fat diet exhibited significantly less cardiac fibrosis than controls, indicating that NLRP3 is an essential protein that promotes cardiac fibrosis [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. Chen and colleagues recently revealed that NLRP3 inflammasome activation enhances the migration and activation of cardiac fibroblasts, thereby exacerbating heart damage and accelerating fibrosis [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>]. Notably, the NLRP3 inflammasome can also be triggered by several environmental pollutants, including fine particles (PM2.5) and radiation, both of which are important factors in inducing pulmonary fibrosis [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>–<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. Research illustrated that the NLRP3 inflammasome enhances epithelial-mesenchymal transformation (EMT) and induces lung inflammation and fibrosis by activating TGF-β1/Smad pathway [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>, <a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>].</p></section><section id="Sec15"><h3 class="pmc_sec_title">Cancers</h3>
<p id="Par23">Cancer has become a major public health issue that jeopardizes human health worldwide, with its occurrence and development being diverse and complicated [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. Many investigations have revealed that inflammation significantly contributes to cancer progression, and the NLRP3 inflammasome is considered to be involved in this process due to its induction of pro-inflammatory cytokines, such as IL-1β and IL-18, and its activation of critical inflammatory signaling cascades, including the NF-κB pathway [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. Research reveals that there is significantly enhanced NLRP3 activity in multiple oncological tissues compared to healthy control tissues [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. The NLRP3 inflammasome complex exhibits context-dependent duality in tumorigenesis, demonstrating both pro- and anti-tumorigenic effects contingent upon microenvironmental factors [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. For instance, NLRP3 inflammasome-triggered pyroptosis enhances the effectiveness of anticancer agents in colorectal cancer, while decreased NLRP3 levels are linked to a poor prognosis in the disease [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>]. Conversely, in breast cancer, IL-1β facilitates the invasion, migration, and EMT of breast carcinoma cells [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. Emerging evidence highlights the oncogenic potential of NLRP3 inflammasome activation via pyroptotic pathways in breast carcinogenesis [<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>, <a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. Moreover, investigations have confirmed that elevated NLRP3 levels are among the critical factors contributing to the growth and metastasis of cancer cells in various malignancies, such as lung carcinoma [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>]. Considering the context-dependent dual effects of the NLRP3 inflammasome in different cancers, further investigation is essential to explore its specific contributions to cancer progression.</p></section></section><section id="Sec16"><h2 class="pmc_sec_title">NLRP3 inflammasome: an important component of PANoptosis</h2>
<p id="Par24">The term “PANoptosis” was originally proposed and defined in 2019 by a research team led by Professor Kanneganti [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]. Their research discovered a unique protein complex that can trigger a programmed cell death pattern, concurrently exhibiting features of pyroptosis, apoptosis, and necrosis [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]. This complex was later named the PANoptosome [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. Prior to the introduction of the concept of PANoptosis, considerable evidence indicated significant crosstalk among the key regulatory molecules of certain cell death pathways [<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>–<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. The discovery of PANoptosis provides critical mechanistic insights into the crosstalk between various cell death processes. Previous research on the NLRP3 inflammasome has largely focused on a single form of cell death, for instance, pyroptosis. Nevertheless, recent investigations have identified the NLRP3 inflammasome as a key element in several PANoptosome complexes that induce PANoptosis (Fig. <a href="#Fig3" class="usa-link">3</a>). PANoptosis, a pivotal effector mechanism in innate immunity, can be triggered through multiple pathophysiological stimuli, including microbial pathogen invasion, tissue damage, inflammatory signaling cascades, and oncogenic transformation [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]. Extensive research has identified the involvement of PANoptosis in infection pathology, autoimmune disorders, inflammatory diseases, and the development of cancer [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>].</p>
<figure class="fig xbox font-sm" id="Fig3"><h3 class="obj_head">Fig. 3. Molecular mechanism of NLRP3-dependent PANoptosis.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365032_41420_2025_2689_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/352a7f768b45/41420_2025_2689_Fig3_HTML.jpg" loading="lazy" id="d33e903" height="560" width="790" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>When stimuli such as microbial infections or changes in cellular homeostasis are detected by intracellular sensor molecules, including ZBP1, AIM2, RIPK1, NLRP12, and NLRC5, certain cell death molecules are recruited to form a PANoptosome. NLRP3 is mainly involved in the formation of the ZBP1-PANoptosome (ZBP1, NLRP3, ASC, Caspase-1, RIPK3, Caspase8, and Caspase 6), the RIPK1-PANoptosome (RIPK1, NLRP3, ASC, Caspase 1, RIPK3, and Caspase8), the NLRP12-PANoptosome (NLRP12, NLRP3, ASC, Caspase 1, RIPK3, and Caspase8) and the NLRC5-PANoptosome (NLRC5, NLRP3, ASC, NLRP12, RIPK3, and Caspase8). These PANoptosomes further induce downstream Caspase 1 activation-mediated GSDMD cleavage, Caspase 3/7 activation-mediated GSDME cleavage, and RIPK3-mediated MLKL phosphorylation, promoting membrane pore formation and PANoptosis.</p></figcaption></figure><p id="Par25">PANoptosis is mediated by specialized PANoptosome complexes that drive divergent phenotypic outcomes through distinct downstream molecular cascades. Currently, various PANoptosome complexes have been discovered, including Z-DNA-binding protein 1 (ZBP1), AIM2, NLR family pyrin domain-containing 12 (NLRP12), receptor-interacting serine/threonine-protein kinase 1 (RIPK1), and the recently characterized NLR family Caspase recruitment domain-containing 5 (NLRC5)- PANoptosomes [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>, <a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]. Notably, NLRP3 serves as a core regulatory component critical for the formation and activation of the ZBP1-, RIPK1-, NLRP12-, and NLRC5-PANoptosome. The ZBP1-PANoptosome, comprising ZBP1, NLRP3, ASC, Caspase-1, RIPK3, RIPK1, and Caspase-8, which were first identified in the context of influenza A virus (IAV) infection [<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]. Mechanistically, ZBP1 acts as a sensor molecule that specifically detects viral RNA through its Zα2 domain. It subsequently recruits the NLRP3 inflammasome, inducing caspase-1-mediated pyroptosis and facilitating the liberation of inflammatory cytokines. Furthermore, the ZBP1-NLRP3 inflammasome can also interact with RIPKs and caspase-8 to assemble the ZBP1-PANoptosome. This process culminates in the sequential activation of caspase-3/7 and mixed lineage kinase domain-like pseudokinase (MLKL), which triggers apoptosis, necrosis, and PANoptosis [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>, <a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]. Additionally, recent reports have found that caspase-6 promotes the binding of ZBP1 to RIPK3, facilitating the subsequent assembly of the ZBP1-PANoptosome [<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>, <a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. Therefore, NLRP3 inflammasome regulates PANoptosis via two primary mechanisms: first, it directly induces pyroptosis and facilitates the maturation of inflammatory factors; second, it participates in PANoptosome assembly to execute PANoptosis processes. Similarly, the NLRP3 inflammasome contributes to the generation of the RIPK1-PANoptosome, which forms protein complexes with RIPK1, RIPK3, and Caspase-8[<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>]. Transforming growth factor-β (TGF-β)-activated kinase 1 (TAK1) is a crucial kinase that plays a vital role in preserving NLRP3 inflammasome inactivity and cellular homeostasis [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]. The RIPK1-PANoptosome complex is typically assembled in the absence or inhibition of TAK1 (TAK1i) and during Yersinia infection, while also requiring stimulation with LPS [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. The NLRP12-PANoptosome complex, produced by heme combined with PAMPs or TNF stimulation, was found to contain NLRP12, NLRP3, ASC, Caspase-1, RIPK3, and Caspase-8, although the complex can still form in the absence of NLRP3 [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]. NLRC5 is an enigmatic NLR sensor responding to bacterial infections, DAMPs, and PAMPs, and is involved in regulating NLRP3 inflammasome activation. Recently, Kanneganti et al. identified that NLRC5 associates with NLRP12, NLRP3, Caspase-8, and other molecules involved in cell death after recognizing various stimuli, forming the NLRC5-PANoptosome to trigger PANoptosis [<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]. Their research confirms the pivotal involvement of NLRC5-mediated cell death in causing tissue damage and inflammation [<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]. It is particularly noteworthy that there may be other unidentified sensor-specific PANoptosomes that form under certain external stimuli or homeostasis disorders. Remarkably, although NLRP3 is acknowledged as the most canonical inflammasome sensor in the NLR family, its roles and functions in the formation of PANoptosomes still require further exploration.</p></section><section id="Sec17"><h2 class="pmc_sec_title">Targeting strategies for NLRP3</h2>
<p id="Par26">The undeniable link between NLRP3 inflammasome activation, cell death, and human disease makes NLRP3 inhibitors an important focus for future research. The potential of wide-ranging therapeutic applications for small-molecule NLRP3 inhibitors that are both selective and potent has prompted their development and discovery (Table <a href="#Tab2" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Compounds that target NLRP3.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Compound name</th>
<th colspan="1" rowspan="1">Structure</th>
<th colspan="1" rowspan="1">Clinical development stage</th>
<th colspan="1" rowspan="1">Indications</th>
<th colspan="1" rowspan="1">Ref</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">CRID3 (MCC950, CP-456773)</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/8ebe568b8458/41420_2025_2689_Taba_HTML.gif" loading="lazy" id="d33e984" height="115" width="100" alt="graphic file with name 41420_2025_2689_Taba_HTML.gif"></td>
<td colspan="1" rowspan="1">Phase II</td>
<td colspan="1" rowspan="1">Rheumatoid arthritis (RA)</td>
<td colspan="1" rowspan="1">[<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ZYIL1</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/64ac0fd8c8ae/41420_2025_2689_Tabb_HTML.gif" loading="lazy" id="d33e1001" height="117" width="100" alt="graphic file with name 41420_2025_2689_Tabb_HTML.gif"></td>
<td colspan="1" rowspan="1">Phase II, <a href="https://clinicaltrials.gov/ct2/show/NCT05186051" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05186051</a>
</td>
<td colspan="1" rowspan="1">Cryopyrin-associated periodic syndrome (CAPS)</td>
<td colspan="1" rowspan="1">[<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DFV890</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/a1a1cb763775/41420_2025_2689_Tabc_HTML.gif" loading="lazy" id="d33e1018" height="80" width="140" alt="graphic file with name 41420_2025_2689_Tabc_HTML.gif"></td>
<td colspan="1" rowspan="1">
<p>Phase II, <a href="https://clinicaltrials.gov/ct2/show/NCT04868968" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04868968</a></p>
<p>Phase II, <a href="https://clinicaltrials.gov/ct2/show/NCT04886258" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04886258</a></p>
</td>
<td colspan="1" rowspan="1">
<p>Familial cold autoinflammatory syndrome (FCAS)</p>
<p>Knee osteoarthritis</p>
</td>
<td colspan="1" rowspan="1">[<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Selnoflast</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/81fb1f586c44/41420_2025_2689_Tabd_HTML.gif" loading="lazy" id="d33e1037" height="106" width="100" alt="graphic file with name 41420_2025_2689_Tabd_HTML.gif"></td>
<td colspan="1" rowspan="1">Phase I, <a href="https://clinicaltrials.gov/ct2/show/NCT04086602" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04086602</a>
</td>
<td colspan="1" rowspan="1">Cryopyrin-associated periodic syndrome (CAPS)</td>
<td colspan="1" rowspan="1">[<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Dapansutrile (OLT1177)</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/c70b568395ee/41420_2025_2689_Tabe_HTML.gif" loading="lazy" id="d33e1054" height="80" width="167" alt="graphic file with name 41420_2025_2689_Tabe_HTML.gif"></td>
<td colspan="1" rowspan="1">
<p>Phase II, <a href="https://clinicaltrials.gov/ct2/show/NCT01768975" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01768975</a></p>
<p>Phase II, EudraCT number 2016-000943-14</p>
<p>Phase II, <a href="https://clinicaltrials.gov/ct2/show/NCT03595371" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03595371</a></p>
<p>Phase I / II trial, <a href="https://clinicaltrials.gov/ct2/show/NCT04971499" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04971499</a></p>
</td>
<td colspan="1" rowspan="1">
<p>Early-stage osteoarthritis</p>
<p>Acute gout</p>
<p>Schnitzler syndrome</p>
<p>PD-1-resistant advanced melanoma</p>
</td>
<td colspan="1" rowspan="1">[<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>, <a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CY-09</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/418c9e4cfbc9/41420_2025_2689_Tabf_HTML.gif" loading="lazy" id="d33e1080" height="470" width="181" alt="graphic file with name 41420_2025_2689_Tabf_HTML.gif"></td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">[<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">JC-171</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/61afc8cd5339/41420_2025_2689_Tabg_HTML.gif" loading="lazy" id="d33e1097" height="205" width="100" alt="graphic file with name 41420_2025_2689_Tabg_HTML.gif"></td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">[<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Colchicine</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/714d6ba72ba9/41420_2025_2689_Tabh_HTML.gif" loading="lazy" id="d33e1114" height="103" width="100" alt="graphic file with name 41420_2025_2689_Tabh_HTML.gif"></td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">[<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Glabridin</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/0e2d9861fccc/41420_2025_2689_Tabi_HTML.gif" loading="lazy" id="d33e1131" height="80" width="116" alt="graphic file with name 41420_2025_2689_Tabi_HTML.gif"></td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">[<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Oridonin</td>
<td colspan="1" rowspan="1"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d0/12365032/62a434b676fa/41420_2025_2689_Tabj_HTML.gif" loading="lazy" id="d33e1148" height="96" width="100" alt="graphic file with name 41420_2025_2689_Tabj_HTML.gif"></td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">NA</td>
<td colspan="1" rowspan="1">[<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par27">MCC950 is currently the most widely studied NLRP3 inhibitor [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. It was originally named CP-456,773 (CRID3) and was discovered through phenotypic screening of monocytes or macrophages that produce IL-1β [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>]. Due to its specificity as an inhibitor of NLRP3 inflammasome activation, rather than targeting other inflammasomes, MCC950 is widely used in animal models of inflammatory disorders involving the NLRP3 inflammasome [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]. Although MCC950 demonstrated excellent targeting, the phase II clinical trial for RA treatment was terminated due to apparent liver toxicity [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]. Regardless, the discovery of MCC950 provides inspiration and momentum for improved NLRP3 second-generation inhibitors, some of which are already in clinical trials. ZYIL1, an analog of MCC950, has been shown to be safe and effective as an NLRP3 small molecule inhibitor in phase I clinical trials [<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>]. Its phase II clinical trial in CAPS patients has recently been completed (<a href="https://clinicaltrials.gov/ct2/show/NCT05186051" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05186051</a>), and the published outcomes illustrate that ZYIL1 administration greatly reduced the levels of inflammatory markers in these patients and improved their general health status [<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>]. DFV890, a recently developed NLRP3 antagonist, has demonstrated favorable tolerability profiles in clinical studies. Both single- and multiple-ascending dose trials in healthy volunteers revealed no safety concerns [<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]. Although the compound failed to demonstrate statistically significant clinical improvement compared to standard care in a phase II trial for COVID-19-related pneumonia [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>], a recent investigation by Shen et al. revealed its superior pharmacokinetic properties relative to MCC950 and demonstrated effective therapeutic efficacy in murine models of acute gout [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]. Currently, several phase II clinical trials are being conducted to evaluate the therapeutic efficacy of this inhibitor across multiple indications, including familial cold autoinflammatory syndrome (FCAS) (<a href="https://clinicaltrials.gov/ct2/show/NCT04868968" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04868968</a>) and knee osteoarthritis (<a href="https://clinicaltrials.gov/ct2/show/NCT04886258" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04886258</a>). Selnoflast (a CRID3 derivative), developed by Roche Pharmaceuticals, has successfully completed phase I clinical trials involving both healthy volunteers and patients with CAPS (<a href="https://clinicaltrials.gov/ct2/show/NCT04086602" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04086602</a>) [<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>]. Selnoflast primarily inhibits the ATP/ADP exchange and ATPase activity of the NLRP3 inflammasome by attaching to its ATP-binding Walker region or adjacent areas. As a second-generation derivative of CRID3, Selnoflast features a piperidine moiety that replaces the isopropyl furan moiety in CRID3’s structure, thereby exhibiting enhanced pharmacological potency and improved functional properties[<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. Based on its good safety characteristics and preliminary efficacy data, this compound is poised for further development in treating systemic inflammatory disorders, including ulcerative colitis [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>]. Dapansutrile (OLT1177) is an orally bioavailable NLRP3 inflammasome inhibitor that has been evaluated for safety in healthy subjects and has been found to be well tolerated [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>]. It primarily inhibits the ATP-induced conformational changes of NLRP3 by specifically binding to the ATP-binding site in the NACHT domain, thereby preventing NLRP3 from interacting with ASC. This effect directly intervenes in the crucial initial step of inflammasome assembly, preventing the recruitment of ASC and the aggregation of pro-caspase-1 [<a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>]. Phase II clinical trials investigating early-stage osteoarthritis (<a href="https://clinicaltrials.gov/ct2/show/NCT01768975" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01768975</a>) and acute gout (EudraCT number 2016-000943-14) have revealed preliminary therapeutic efficacy [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. Furthermore, an ongoing phase II clinical study is evaluating its therapeutic potential in patients with Schnitzler syndrome (<a href="https://clinicaltrials.gov/ct2/show/NCT03595371" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03595371</a>). Although clinical investigations of single NLRP3 inhibitors in cancer therapy remain limited, a phase I/ II trial (<a href="https://clinicaltrials.gov/ct2/show/NCT04971499" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04971499</a>) is currently underway to evaluate Dapansutrile combination with Pembrolizumab in patients with PD-1-resistant advanced melanoma[<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. Moreover, the latest research shows that in vitro and in vivo models of breast cancer demonstrate a better therapeutic effect with the combination of Dapansutrile compared to single-agent anti-PD-1 treatment [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. Therefore, the combination therapy of NLRP3 inhibitors is anticipated to become a potential direction for future cancer treatments, including breast cancer.</p>
<p id="Par28">Notably, before the identification of inflammasomes, the antidiabetic agent glyburide had already been shown to effectively suppress IL-1β release [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>]. Subsequent studies have demonstrated that this drug selectively blocks NLRP3 inflammasome-mediated IL-1β release without influencing the activation of other inflammasomes [<a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>]. Although several second-generation glyburide-derived analogs, including CY-09 and JC-171, have been developed, they all currently remain in the preclinical development phase [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>, <a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]. Furthermore, several natural compounds have been determined as inhibitors of NLRP3 inflammasome activation. These include colchicine (derived from <em>Colchicum autumnale</em>) [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>], glabridin (isolated from <em>licorice</em>) [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>], and oridonin (the primary bioactive constituent of the Chinese herbal medicine <em>Rabdosia rubescens</em>) [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>], all of which have demonstrated anti-inflammatory effects via targeted suppression of the NLRP3 inflammasome [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>].</p></section><section id="Sec18"><h2 class="pmc_sec_title">Summary and future perspectives</h2>
<p id="Par29">Since the discovery of the NLRP3 inflammasome as a key component of the innate immune system, there has been a rapid expansion in the understanding of its activation regulation, signal transduction pathways, and role in various diseases. These findings lay the foundation for further insights into inflammasome mechanisms in autoimmune, metabolic, neuropathic, inflammatory, and oncological conditions, and they offer potential directions for the development of future therapeutic strategies.</p>
<p id="Par30">Recently, scientists have discovered a novel protein complex termed the PANoptosome, which mediates a distinct type of cell death called PANoptosis. This discovery explains the complex interrelationships among the three main PCD pathways—pyroptosis, apoptosis, and necrosis—that exist in various disease models. Substantial experimental evidence has established PANoptosis as a critical mediator in diverse pathological processes, including viral and bacterial infections, inflammatory diseases, autoimmune disorders, oncogenesis, and multi-organ dysfunction. While the precise mechanistic pathways are not yet fully characterized, emerging insights suggest potential pathogenic overlap with NLRP3-associated disorders [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>]. For example, TNF-α, a key inflammatory factor that induces NLRP12-PANoptosome activation, has been reported to be significantly elevated in SLE patients, thereby accelerating the progression of the disease [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Sun et al. also illustrated that PANoptosis is closely related to the imbalance of immune homeostasis in SLE [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>]. In the context of metabolic diseases, multiple inflammatory mediators and DAMPs induce PANoptosis in cells across diverse metabolic tissues, particularly in the liver and pancreas, thereby contributing to the pathogenesis of IR [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>, <a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>]. Moreover, the regulatory impact of PANoptosis in the tumor microenvironment has been gradually explored, and it is believed to hold significant promise for future tumor therapies [<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>]. It would be interesting to further explore NLRP3’s specific function in the generation of the PANoptosome complex and its involvement in the regulation of PANoptosis in different diseases.</p>
<p id="Par31">With the maturation of inflammasome studies, significant advancements have been made in comprehending NLRP3 regulation. At the same time, researchers are working to develop effective NLRP3 inhibitors, some of which are already being used in clinical studies for various diseases. Although small-molecule chemical inhibitors and natural compounds targeting NLRP3 presented considerable therapeutic efficacy and ease of administration, their safety profiles remain a critical challenge that requires urgent resolution. The potential toxicity observed in clinical trials of candidate drugs like MCC950 highlights the importance of safety evaluation during drug development. The primary mission of future scientists and biopharmaceutical companies is to design safer and more efficient NLRP3 inhibitors. Consequently, advancing our understanding of NLRP3 activation mechanisms, its contributions to cell death pathways, and its implications across various disease contexts remains imperative.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Funding for this work was provided by the Suzhou Science and Technology Development Plan Project (SYWD2024173, SKYD2023056-A, SYW2024045, SKY2023008), the Jiangsu Medical Vocational College Campus Local Collaborative Innovation Project (20239616, 20239608), National Natural Science Foundation of China (82104892, 82405281), the Suzhou Science and Education Strong Health Project (ZDXM2024016), 2024 Jiangsu Province Traditional Chinese Medicine Science and Technology Development Program Project-83, and 2024 Annual Research Project of Jiangsu Association of Traditional Chinese Medicine-47. We express our deep gratitude for the groundbreaking contributions of numerous scientists in the field and regret that some contributions are not mentioned because of limited space.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Yuanyuan Jiang, Zhiyuan Qiang, and Yue Liu conceived the concept and designed the manuscript. Yuanyuan Jiang and Rong Cai illustrated figures and tables. Liwei Zhu and Long Xiao collected the related papers. Zhenfang Du and Sheng Qiang revised the manuscript and provided financial support. All authors reviewed and approved the final manuscript.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par32">The authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
<div class="fn p" id="fn2"><p>These authors contributed equally: Yuanyuan Jiang, Zhiyuan Qiang, Yue Liu.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Zhenfang Du, Email: zjgzy089@njucm.edu.cn.</p>
<p>Rong Cai, Email: 1040631782@qq.com.</p>
<p>Sheng Qiang, Email: zjgzy018@njucm.edu.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.
</cite> [<a href="https://doi.org/10.1016/j.cell.2006.02.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16497588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akira%20S,%20Uematsu%20S,%20Takeuchi%20O.%20Pathogen%20recognition%20and%20innate%20immunity.%20Cell.%202006;124:783%E2%80%93801." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Tomalka JA, Suthar MS, Diamond MS, Sekaly RP. Innate antiviral immunity: how prior exposures can guide future responses. Trends Immunol. 2022;43:696–705.
</cite> [<a href="https://doi.org/10.1016/j.it.2022.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35907675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tomalka%20JA,%20Suthar%20MS,%20Diamond%20MS,%20Sekaly%20RP.%20Innate%20antiviral%20immunity:%20how%20prior%20exposures%20can%20guide%20future%20responses.%20Trends%20Immunol.%202022;43:696%E2%80%93705." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477–89.
</cite> [<a href="https://doi.org/10.1038/s41577-019-0165-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7807242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31036962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Swanson%20KV,%20Deng%20M,%20Ting%20JP.%20The%20NLRP3%20inflammasome:%20molecular%20activation%20and%20regulation%20to%20therapeutics.%20Nat%20Rev%20Immunol.%202019;19:477%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Christgen S, Place DE, Kanneganti TD. Toward targeting inflammasomes: insights into their regulation and activation. Cell Res. 2020;30:315–27.
</cite> [<a href="https://doi.org/10.1038/s41422-020-0295-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7118104/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32152420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Christgen%20S,%20Place%20DE,%20Kanneganti%20TD.%20Toward%20targeting%20inflammasomes:%20insights%20into%20their%20regulation%20and%20activation.%20Cell%20Res.%202020;30:315%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21:677–87.
</cite> [<a href="https://doi.org/10.1038/nm.3893" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4519035/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26121197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20H,%20Callaway%20JB,%20Ting%20JP.%20Inflammasomes:%20mechanism%20of%20action,%20role%20in%20disease,%20and%20therapeutics.%20Nat%20Med.%202015;21:677%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301–16.
</cite> [<a href="https://doi.org/10.1146/annurev-immunol-081022-021207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10159982/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36750315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20J,%20Wu%20H.%20Structural%20mechanisms%20of%20NLRP3%20inflammasome%20assembly%20and%20activation.%20Annu%20Rev%20Immunol.%202023;41:301%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18:2114–27.
</cite> [<a href="https://doi.org/10.1038/s41423-021-00740-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8429580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34321623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Xu%20W,%20Zhou%20R.%20NLRP3%20inflammasome%20activation%20and%20cell%20death.%20Cell%20Mol%20Immunol.%202021;18:2114%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, et al. NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev. 2020;2020:4063562.
</cite> [<a href="https://doi.org/10.1155/2020/4063562" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7049400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32148650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z,%20Zhang%20S,%20Xiao%20Y,%20Zhang%20W,%20Wu%20S,%20Qin%20T,%20et%20al.%20NLRP3%20inflammasome%20and%20inflammatory%20diseases.%20Oxid%20Med%20Cell%20Longev.%202020;2020:4063562." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235–56.
</cite> [<a href="https://doi.org/10.1016/j.cell.2023.11.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38242081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Newton%20K,%20Strasser%20A,%20Kayagaki%20N,%20Dixit%20VM.%20Cell%20death.%20Cell.%202024;187:235%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Nagata S, Tanaka M. Programmed cell death and the immune system. Nat Rev Immunol. 2017;17:333–40.
</cite> [<a href="https://doi.org/10.1038/nri.2016.153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28163302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagata%20S,%20Tanaka%20M.%20Programmed%20cell%20death%20and%20the%20immune%20system.%20Nat%20Rev%20Immunol.%202017;17:333%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18:1106–21.
</cite> [<a href="https://doi.org/10.1038/s41423-020-00630-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8008022/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33785842/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bertheloot%20D,%20Latz%20E,%20Franklin%20BS.%20Necroptosis,%20pyroptosis%20and%20apoptosis:%20an%20intricate%20game%20of%20cell%20death.%20Cell%20Mol%20Immunol.%202021;18:1106%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347–64.
</cite> [<a href="https://doi.org/10.1038/s41422-019-0164-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6796845/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30948788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20D,%20Kang%20R,%20Berghe%20TV,%20Vandenabeele%20P,%20Kroemer%20G.%20The%20molecular%20machinery%20of%20regulated%20cell%20death.%20Cell%20Res.%202019;29:347%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Sun X, Yang Y, Meng X, Li J, Liu X, Liu H. PANoptosis: mechanisms, biology, and role in disease. Immunol Rev. 2024;321:246–62.
</cite> [<a href="https://doi.org/10.1111/imr.13279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37823450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20X,%20Yang%20Y,%20Meng%20X,%20Li%20J,%20Liu%20X,%20Liu%20H.%20PANoptosis:%20mechanisms,%20biology,%20and%20role%20in%20disease.%20Immunol%20Rev.%202024;321:246%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Ocansey DKW, Qian F, Cai P, Ocansey S, Amoah S, Qian Y, et al. Current evidence and therapeutic implication of PANoptosis in cancer. Theranostics. 2024;14:640–61.
</cite> [<a href="https://doi.org/10.7150/thno.91814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10758053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38169587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ocansey%20DKW,%20Qian%20F,%20Cai%20P,%20Ocansey%20S,%20Amoah%20S,%20Qian%20Y,%20et%20al.%20Current%20evidence%20and%20therapeutic%20implication%20of%20PANoptosis%20in%20cancer.%20Theranostics.%202024;14:640%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297:26–38.
</cite> [<a href="https://doi.org/10.1111/imr.12909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7811275/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32729116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20M,%20Kanneganti%20TD.%20The%20regulation%20of%20the%20ZBP1-NLRP3%20inflammasome%20and%20its%20implications%20in%20pyroptosis,%20apoptosis,%20and%20necroptosis%20(PANoptosis).%20Immunol%20Rev.%202020;297:26%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Duncan JA, Canna SW. The NLRC4 inflammasome. Immunol Rev. 2018;281:115–23.
</cite> [<a href="https://doi.org/10.1111/imr.12607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5897049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29247997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duncan%20JA,%20Canna%20SW.%20The%20NLRC4%20inflammasome.%20Immunol%20Rev.%202018;281:115%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22:550–9.
</cite> [<a href="https://doi.org/10.1038/s41590-021-00886-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8132572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33707781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sharma%20BR,%20Kanneganti%20TD.%20NLRP3%20inflammasome%20in%20cancer%20and%20metabolic%20diseases.%20Nat%20Immunol.%202021;22:550%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>McKee CM, Coll RC. NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma. J Leukoc Biol. 2020;108:937–52.
</cite> [<a href="https://doi.org/10.1002/JLB.3MR0720-513R" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32745339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McKee%20CM,%20Coll%20RC.%20NLRP3%20inflammasome%20priming:%20a%20riddle%20wrapped%20in%20a%20mystery%20inside%20an%20enigma.%20J%20Leukoc%20Biol.%202020;108:937%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18:1141–60.
</cite> [<a href="https://doi.org/10.1038/s41423-021-00670-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8093260/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33850310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paik%20S,%20Kim%20JK,%20Silwal%20P,%20Sasakawa%20C,%20Jo%20EK.%20An%20update%20on%20the%20regulatory%20mechanisms%20of%20NLRP3%20inflammasome%20activation.%20Cell%20Mol%20Immunol.%202021;18:1141%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Tang T, Lang X, Xu C, Wang X, Gong T, Yang Y, et al. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat Commun. 2017;8:202.
</cite> [<a href="https://doi.org/10.1038/s41467-017-00227-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5544706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28779175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20T,%20Lang%20X,%20Xu%20C,%20Wang%20X,%20Gong%20T,%20Yang%20Y,%20et%20al.%20CLICs-dependent%20chloride%20efflux%20is%20an%20essential%20and%20proximal%20upstream%20event%20for%20NLRP3%20inflammasome%20activation.%20Nat%20Commun.%202017;8:202." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM, Núñez GK. efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38:1142–53.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2013.05.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3730833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23809161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mu%C3%B1oz-Planillo%20R,%20Kuffa%20P,%20Mart%C3%ADnez-Col%C3%B3n%20G,%20Smith%20BL,%20Rajendiran%20TM,%20N%C3%BA%C3%B1ez%20GK.%20efflux%20is%20the%20common%20trigger%20of%20NLRP3%20inflammasome%20activation%20by%20bacterial%20toxins%20and%20particulate%20matter.%20Immunity.%202013;38:1142%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221–5.
</cite> [<a href="https://doi.org/10.1038/nature09663" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21124315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20R,%20Yazdi%20AS,%20Menu%20P,%20Tschopp%20J.%20A%20role%20for%20mitochondria%20in%20NLRP3%20inflammasome%20activation.%20Nature.%202011;469:221%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Ma Q. Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction. Pharm Rev. 2023;75:487–520.
</cite> [<a href="https://doi.org/10.1124/pharmrev.122.000629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10121800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36669831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20Q.%20Pharmacological%20inhibition%20of%20the%20NLRP3%20inflammasome:%20structure,%20molecular%20activation,%20and%20inhibitor-NLRP3%20interaction.%20Pharm%20Rev.%202023;75:487%E2%80%93520." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Moretti J, Jia B, Hutchins Z, Roy S, Yip H, Wu J, et al. Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome. Nat Immunol. 2022;23:705–17.
</cite> [<a href="https://doi.org/10.1038/s41590-022-01192-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9106893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35487985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moretti%20J,%20Jia%20B,%20Hutchins%20Z,%20Roy%20S,%20Yip%20H,%20Wu%20J,%20et%20al.%20Caspase-11%20interaction%20with%20NLRP3%20potentiates%20the%20noncanonical%20activation%20of%20the%20NLRP3%20inflammasome.%20Nat%20Immunol.%202022;23:705%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Casson CN, Yu J, Reyes VM, Taschuk FO, Yadav A, Copenhaver AM, et al. Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens. Proc Natl Acad Sci USA. 2015;112:6688–93.
</cite> [<a href="https://doi.org/10.1073/pnas.1421699112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4450384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25964352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Casson%20CN,%20Yu%20J,%20Reyes%20VM,%20Taschuk%20FO,%20Yadav%20A,%20Copenhaver%20AM,%20et%20al.%20Human%20caspase-4%20mediates%20noncanonical%20inflammasome%20activation%20against%20gram-negative%20bacterial%20pathogens.%20Proc%20Natl%20Acad%20Sci%20USA.%202015;112:6688%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Downs KP, Nguyen H, Dorfleutner A, Stehlik C. An overview of the non-canonical inflammasome. Mol Asp Med. 2020;76:100924.</cite> [<a href="https://doi.org/10.1016/j.mam.2020.100924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7808250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33187725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Downs%20KP,%20Nguyen%20H,%20Dorfleutner%20A,%20Stehlik%20C.%20An%20overview%20of%20the%20non-canonical%20inflammasome.%20Mol%20Asp%20Med.%202020;76:100924." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Rühl S, Broz P. Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux. Eur J Immunol. 2015;45:2927–36.
</cite> [<a href="https://doi.org/10.1002/eji.201545772" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26173909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?R%C3%BChl%20S,%20Broz%20P.%20Caspase-11%20activates%20a%20canonical%20NLRP3%20inflammasome%20by%20promoting%20K(+)%20efflux.%20Eur%20J%20Immunol.%202015;45:2927%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Zanoni I, Tan Y, Di Gioia M, Broggi A, Ruan J, Shi J, et al. An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science. 2016;352:1232–6.
</cite> [<a href="https://doi.org/10.1126/science.aaf3036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5111085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27103670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zanoni%20I,%20Tan%20Y,%20Di%20Gioia%20M,%20Broggi%20A,%20Ruan%20J,%20Shi%20J,%20et%20al.%20An%20endogenous%20caspase-11%20ligand%20elicits%20interleukin-1%20release%20from%20living%20dendritic%20cells.%20Science.%202016;352:1232%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76:473–93.
</cite> [<a href="https://doi.org/10.1007/s00018-018-2943-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11105460/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30317530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Adak%20A,%20Khan%20MR.%20An%20insight%20into%20gut%20microbiota%20and%20its%20functionalities.%20Cell%20Mol%20Life%20Sci.%202019;76:473%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>He Y, Franchi L, Núñez G. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol. 2013;190:334–9.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1202737" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3531812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23225887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He%20Y,%20Franchi%20L,%20N%C3%BA%C3%B1ez%20G.%20TLR%20agonists%20stimulate%20Nlrp3-dependent%20IL-1%CE%B2%20production%20independently%20of%20the%20purinergic%20P2X7%20receptor%20in%20dendritic%20cells%20and%20in%20vivo.%20J%20Immunol.%202013;190:334%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50:778–95.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2019.03.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7174020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30995499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mantovani%20A,%20Dinarello%20CA,%20Molgora%20M,%20Garlanda%20C.%20Interleukin-1%20and%20related%20cytokines%20in%20the%20regulation%20of%20inflammation%20and%20immunity.%20Immunity.%202019;50:778%E2%80%9395." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Li SJ, Wu YL, Chen JH, Shen SY, Duan J, Xu HE. Autoimmune diseases: targets, biology, and drug discovery. Acta Pharm Sin. 2024;45:674–85.</cite> [<a href="https://doi.org/10.1038/s41401-023-01207-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10943205/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38097717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20SJ,%20Wu%20YL,%20Chen%20JH,%20Shen%20SY,%20Duan%20J,%20Xu%20HE.%20Autoimmune%20diseases:%20targets,%20biology,%20and%20drug%20discovery.%20Acta%20Pharm%20Sin.%202024;45:674%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Su X, Yu H, Lei Q, Chen X, Tong Y, Zhang Z, et al. Systemic lupus erythematosus: pathogenesis and targeted therapy. Mol Biomed. 2024;5:54.
</cite> [<a href="https://doi.org/10.1186/s43556-024-00217-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11522254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39472388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20X,%20Yu%20H,%20Lei%20Q,%20Chen%20X,%20Tong%20Y,%20Zhang%20Z,%20et%20al.%20Systemic%20lupus%20erythematosus:%20pathogenesis%20and%20targeted%20therapy.%20Mol%20Biomed.%202024;5:54." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>da Cruz HLA, Cavalcanti CAJ, de Azêvedo Silva J, de Lima CAD, Fragoso TS, Barbosa AD, et al. Differential expression of the inflammasome complex genes in systemic lupus erythematosus. Immunogenetics. 2020;72:217–24.
</cite> [<a href="https://doi.org/10.1007/s00251-020-01158-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32020248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?da%20Cruz%20HLA,%20Cavalcanti%20CAJ,%20de%20Az%C3%AAvedo%20Silva%20J,%20de%20Lima%20CAD,%20Fragoso%20TS,%20Barbosa%20AD,%20et%20al.%20Differential%20expression%20of%20the%20inflammasome%20complex%20genes%20in%20systemic%20lupus%20erythematosus.%20Immunogenetics.%202020;72:217%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Huang T, Yin H, Ning W, Wang X, Chen C, Lin W, et al. Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis. Clin Exp Rheumatol. 2020;38:680–90.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/31694740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20T,%20Yin%20H,%20Ning%20W,%20Wang%20X,%20Chen%20C,%20Lin%20W,%20et%20al.%20Expression%20of%20inflammasomes%20NLRP1,%20NLRP3%20and%20AIM2%20in%20different%20pathologic%20classification%20of%20lupus%20nephritis.%20Clin%20Exp%20Rheumatol.%202020;38:680%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Yang CA, Huang ST, Chiang BL. Sex-dependent differential activation of NLRP3 and AIM2 inflammasomes in SLE macrophages. Rheumatology. 2015;54:324–31.
</cite> [<a href="https://doi.org/10.1093/rheumatology/keu318" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25161312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20CA,%20Huang%20ST,%20Chiang%20BL.%20Sex-dependent%20differential%20activation%20of%20NLRP3%20and%20AIM2%20inflammasomes%20in%20SLE%20macrophages.%20Rheumatology.%202015;54:324%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Erazo-Martínez V, Tobón GJ, Cañas CA. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus. Autoimmun Rev. 2023;22:103262.
</cite> [<a href="https://doi.org/10.1016/j.autrev.2022.103262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36563771/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Erazo-Mart%C3%ADnez%20V,%20Tob%C3%B3n%20GJ,%20Ca%C3%B1as%20CA.%20Circulating%20and%20skin%20biopsy-present%20cytokines%20related%20to%20the%20pathogenesis%20of%20cutaneous%20lupus%20erythematosus.%20Autoimmun%20Rev.%202023;22:103262." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Ghorbaninezhad F, Leone P, Alemohammad H, Najafzadeh B, Nourbakhsh NS, Prete M, et al. Tumor necrosis factor‑α in systemic lupus erythematosus: structure, function and therapeutic implications (Review). Int J Mol Med. 2022;49:43.</cite> [<a href="https://doi.org/10.3892/ijmm.2022.5098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35137914/" class="usa-link">PubMed</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Liu S, Yang M, Liu H, Hao Y, Zhang D. Recent progress in microenvironment-responsive nanodrug delivery systems for the targeted treatment of rheumatoid arthritis. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024;16:e2008.
</cite> [<a href="https://doi.org/10.1002/wnan.2008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39532280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20S,%20Yang%20M,%20Liu%20H,%20Hao%20Y,%20Zhang%20D.%20Recent%20progress%20in%20microenvironment-responsive%20nanodrug%20delivery%20systems%20for%20the%20targeted%20treatment%20of%20rheumatoid%20arthritis.%20Wiley%20Interdiscip%20Rev%20Nanomed%20Nanobiotechnol.%202024;16:e2008." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Gao J, Zhang H, Yang Y, Tao J. Therapeutic potential of targeting the NLRP3 inflammasome in rheumatoid arthritis. Inflammation. 2023;46:835–52.
</cite> [<a href="https://doi.org/10.1007/s10753-023-01795-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36897552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20J,%20Zhang%20H,%20Yang%20Y,%20Tao%20J.%20Therapeutic%20potential%20of%20targeting%20the%20NLRP3%20inflammasome%20in%20rheumatoid%20arthritis.%20Inflammation.%202023;46:835%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Yin H, Liu N, Sigdel KR, Duan L. Role of NLRP3 inflammasome in rheumatoid arthritis. Front Immunol. 2022;13:931690.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.931690" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9271572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35833125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20H,%20Liu%20N,%20Sigdel%20KR,%20Duan%20L.%20Role%20of%20NLRP3%20inflammasome%20in%20rheumatoid%20arthritis.%20Front%20Immunol.%202022;13:931690." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM. Systemic sclerosis in adults. Part I: Clinical features and pathogenesis. J Am Acad Dermatol. 2022;87:937–54.
</cite> [<a href="https://doi.org/10.1016/j.jaad.2021.10.065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35131402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jerjen%20R,%20Nikpour%20M,%20Krieg%20T,%20Denton%20CP,%20Saracino%20AM.%20Systemic%20sclerosis%20in%20adults.%20Part%20I:%20Clinical%20features%20and%20pathogenesis.%20J%20Am%20Acad%20Dermatol.%202022;87:937%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Bai B, Yang Y, Wang Q, Li M, Tian C, Liu Y, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11:776.
</cite> [<a href="https://doi.org/10.1038/s41419-020-02985-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7501262/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32948742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bai%20B,%20Yang%20Y,%20Wang%20Q,%20Li%20M,%20Tian%20C,%20Liu%20Y,%20et%20al.%20NLRP3%20inflammasome%20in%20endothelial%20dysfunction.%20Cell%20Death%20Dis.%202020;11:776." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Martínez-Godínez MA, Cruz-Domínguez MP, Jara LJ, Domínguez-López A, Jarillo-Luna RA, Vera-Lastra O, et al. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients. Isr Med Assoc J. 2015;17:5–10.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/25739168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mart%C3%ADnez-God%C3%ADnez%20MA,%20Cruz-Dom%C3%ADnguez%20MP,%20Jara%20LJ,%20Dom%C3%ADnguez-L%C3%B3pez%20A,%20Jarillo-Luna%20RA,%20Vera-Lastra%20O,%20et%20al.%20Expression%20of%20NLRP3%20inflammasome,%20cytokines%20and%20vascular%20mediators%20in%20the%20skin%20of%20systemic%20sclerosis%20patients.%20Isr%20Med%20Assoc%20J.%202015;17:5%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Lin C, Jiang Z, Cao L, Zou H, Zhu X. Role of NLRP3 inflammasome in systemic sclerosis. Arthritis Res Ther. 2022;24:196.
</cite> [<a href="https://doi.org/10.1186/s13075-022-02889-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9380340/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35974386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20C,%20Jiang%20Z,%20Cao%20L,%20Zou%20H,%20Zhu%20X.%20Role%20of%20NLRP3%20inflammasome%20in%20systemic%20sclerosis.%20Arthritis%20Res%20Ther.%202022;24:196." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Soták M, Clark M, Suur BE, Börgeson E. Inflammation and resolution in obesity. Nat Rev Endocrinol. 2025;21:45–61.</cite> [<a href="https://doi.org/10.1038/s41574-024-01047-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39448830/" class="usa-link">PubMed</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 2010;11:897–904.
</cite> [<a href="https://doi.org/10.1038/ni.1935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3103663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20835230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Masters%20SL,%20Dunne%20A,%20Subramanian%20SL,%20Hull%20RL,%20Tannahill%20GM,%20Sharp%20FA,%20et%20al.%20Activation%20of%20the%20NLRP3%20inflammasome%20by%20islet%20amyloid%20polypeptide%20provides%20a%20mechanism%20for%20enhanced%20IL-1%CE%B2%20in%20type%202%20diabetes.%20Nat%20Immunol.%202010;11:897%E2%80%93904." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7:131.
</cite> [<a href="https://doi.org/10.1038/s41392-022-00955-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9033871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35459215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kong%20P,%20Cui%20ZY,%20Huang%20XF,%20Zhang%20DD,%20Guo%20RJ,%20Han%20M.%20Inflammation%20and%20atherosclerosis:%20signaling%20pathways%20and%20therapeutic%20intervention.%20Signal%20Transduct%20Target%20Ther.%202022;7:131." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Boutari C, DeMarsilis A, Mantzoros CS. Obesity and diabetes. Diab Res Clin Pract. 2023;202:110773.</cite> [<a href="https://doi.org/10.1016/j.diabres.2023.110773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37356727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Boutari%20C,%20DeMarsilis%20A,%20Mantzoros%20CS.%20Obesity%20and%20diabetes.%20Diab%20Res%20Clin%20Pract.%202023;202:110773." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177–85.
</cite> [<a href="https://doi.org/10.1038/nature21363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28179656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hotamisligil%20GS.%20Inflammation,%20metaflammation%20and%20immunometabolic%20disorders.%20Nature.%202017;542:177%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Esser N, L’Homme L, De Roover A, Kohnen L, Scheen AJ, Moutschen M, et al. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia. 2013;56:2487–97.
</cite> [<a href="https://doi.org/10.1007/s00125-013-3023-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24013717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Esser%20N,%20L%E2%80%99Homme%20L,%20De%20Roover%20A,%20Kohnen%20L,%20Scheen%20AJ,%20Moutschen%20M,%20et%20al.%20Obesity%20phenotype%20is%20related%20to%20NLRP3%20inflammasome%20activity%20and%20immunological%20profile%20of%20visceral%20adipose%20tissue.%20Diabetologia.%202013;56:2487%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Kursawe R, Dixit VD, Scherer PE, Santoro N, Narayan D, Gordillo R, et al. A role of the inflammasome in the low storage capacity of the abdominal subcutaneous adipose tissue in obese adolescents. Diabetes. 2016;65:610–8.
</cite> [<a href="https://doi.org/10.2337/db15-1478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4764142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26718495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kursawe%20R,%20Dixit%20VD,%20Scherer%20PE,%20Santoro%20N,%20Narayan%20D,%20Gordillo%20R,%20et%20al.%20A%20role%20of%20the%20inflammasome%20in%20the%20low%20storage%20capacity%20of%20the%20abdominal%20subcutaneous%20adipose%20tissue%20in%20obese%20adolescents.%20Diabetes.%202016;65:610%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179–88.
</cite> [<a href="https://doi.org/10.1038/nm.2279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3076025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21217695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vandanmagsar%20B,%20Youm%20YH,%20Ravussin%20A,%20Galgani%20JE,%20Stadler%20K,%20Mynatt%20RL,%20et%20al.%20The%20NLRP3%20inflammasome%20instigates%20obesity-induced%20inflammation%20and%20insulin%20resistance.%20Nat%20Med.%202011;17:179%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Tai GJ, Yu QQ, Li JP, Wei W, Ji XM, Zheng RF, et al. NLRP3 inflammasome links vascular senescence to diabetic vascular lesions. Pharm Res. 2022;178:106143.</cite> [<a href="https://doi.org/10.1016/j.phrs.2022.106143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35219871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tai%20GJ,%20Yu%20QQ,%20Li%20JP,%20Wei%20W,%20Ji%20XM,%20Zheng%20RF,%20et%20al.%20NLRP3%20inflammasome%20links%20vascular%20senescence%20to%20diabetic%20vascular%20lesions.%20Pharm%20Res.%202022;178:106143." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524–33.
</cite> [<a href="https://doi.org/10.1038/s41586-021-03392-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33883728/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Libby%20P.%20The%20changing%20landscape%20of%20atherosclerosis.%20Nature.%202021;592:524%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357–61.
</cite> [<a href="https://doi.org/10.1038/nature08938" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2946640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20428172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duewell%20P,%20Kono%20H,%20Rayner%20KJ,%20Sirois%20CM,%20Vladimer%20G,%20Bauernfeind%20FG,%20et%20al.%20NLRP3%20inflammasomes%20are%20required%20for%20atherogenesis%20and%20activated%20by%20cholesterol%20crystals.%20Nature.%202010;464:1357%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Tanase DM, Valasciuc E, Gosav EM, Ouatu A, Buliga-Finis ON, Floria M, et al. Portrayal of NLRP3 Inflammasome in atherosclerosis: current knowledge and therapeutic targets. Int J Mol Sci. 2023;24:8162.</cite> [<a href="https://doi.org/10.3390/ijms24098162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10179095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37175869/" class="usa-link">PubMed</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>McManus RM, Latz E. NLRP3 inflammasome signalling in Alzheimer’s disease. Neuropharmacology. 2024;252:109941.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2024.109941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38565393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McManus%20RM,%20Latz%20E.%20NLRP3%20inflammasome%20signalling%20in%20Alzheimer%E2%80%99s%20disease.%20Neuropharmacology.%202024;252:109941." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Han QQ, Le W. NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson’s disease. Neurosci Bull. 2023;39:832–44.
</cite> [<a href="https://doi.org/10.1007/s12264-023-01023-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10169990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36757612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han%20QQ,%20Le%20W.%20NLRP3%20inflammasome-mediated%20neuroinflammation%20and%20related%20mitochondrial%20impairment%20in%20Parkinson%E2%80%99s%20disease.%20Neurosci%20Bull.%202023;39:832%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Shao S, Chen C, Shi G, Zhou Y, Wei Y, Fan N, et al. Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. Pharmacol Ther. 2021;227:107880.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2021.107880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33901504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shao%20S,%20Chen%20C,%20Shi%20G,%20Zhou%20Y,%20Wei%20Y,%20Fan%20N,%20et%20al.%20Therapeutic%20potential%20of%20the%20target%20on%20NLRP3%20inflammasome%20in%20multiple%20sclerosis.%20Pharmacol%20Ther.%202021;227:107880." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Kokkali M, Karali K, Thanou E, Papadopoulou MA, Zota I, Tsimpolis A, et al. Multimodal beneficial effects of BNN27, a nerve growth factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s disease. Mol Psychiatry. 2025;30:2265–83.</cite> [<a href="https://doi.org/10.1038/s41380-024-02833-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12092300/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39587294/" class="usa-link">PubMed</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669–73.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1769-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7324015/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31748742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ising%20C,%20Venegas%20C,%20Zhang%20S,%20Scheiblich%20H,%20Schmidt%20SV,%20Vieira-Saecker%20A,%20et%20al.%20NLRP3%20inflammasome%20activation%20drives%20tau%20pathology.%20Nature.%202019;575:669%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674–8.
</cite> [<a href="https://doi.org/10.1038/nature11729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3812809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23254930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heneka%20MT,%20Kummer%20MP,%20Stutz%20A,%20Delekate%20A,%20Schwartz%20S,%20Vieira-Saecker%20A,%20et%20al.%20NLRP3%20is%20activated%20in%20Alzheimer%E2%80%99s%20disease%20and%20contributes%20to%20pathology%20in%20APP/PS1%20mice.%20Nature.%202013;493:674%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20:385–97.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(21)00030-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8185633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33894193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tolosa%20E,%20Garrido%20A,%20Scholz%20SW,%20Poewe%20W.%20Challenges%20in%20the%20diagnosis%20of%20Parkinson%E2%80%99s%20disease.%20Lancet%20Neurol.%202021;20:385%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Kou L, Chi X, Sun Y, Han C, Wan F, Hu J, et al. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome. J Neuroinflammation. 2022;19:133.
</cite> [<a href="https://doi.org/10.1186/s12974-022-02494-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9169406/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35668454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kou%20L,%20Chi%20X,%20Sun%20Y,%20Han%20C,%20Wan%20F,%20Hu%20J,%20et%20al.%20The%20circadian%20clock%20protein%20Rev-erb%CE%B1%20provides%20neuroprotection%20and%20attenuates%20neuroinflammation%20against%20Parkinson%E2%80%99s%20disease%20via%20the%20microglial%20NLRP3%20inflammasome.%20J%20Neuroinflammation.%202022;19:133." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, Xue NJ, et al. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson’s disease. Aging Cell. 2023;22:e13834.
</cite> [<a href="https://doi.org/10.1111/acel.13834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10265164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37029500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yan%20YQ,%20Zheng%20R,%20Liu%20Y,%20Ruan%20Y,%20Lin%20ZH,%20Xue%20NJ,%20et%20al.%20Parkin%20regulates%20microglial%20NLRP3%20and%20represses%20neurodegeneration%20in%20Parkinson%E2%80%99s%20disease.%20Aging%20Cell.%202023;22:e13834." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Zengeler KE, Lukens JR. Taking the parkin brakes off of neuronal NLRP3 drives inflammasome activation and neurodegeneration in Parkinson’s disease. Neuron. 2022;110:2356–8.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2022.06.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35926449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zengeler%20KE,%20Lukens%20JR.%20Taking%20the%20parkin%20brakes%20off%20of%20neuronal%20NLRP3%20drives%20inflammasome%20activation%20and%20neurodegeneration%20in%20Parkinson%E2%80%99s%20disease.%20Neuron.%202022;110:2356%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Seyedsadr M, Wang Y, Elzoheiry M, Shree Gopal S, Jang S, Duran G, et al. IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system. Proc Natl Acad Sci USA. 2023;120:e2221007120.
</cite> [<a href="https://doi.org/10.1073/pnas.2221007120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10293805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37339207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seyedsadr%20M,%20Wang%20Y,%20Elzoheiry%20M,%20Shree%20Gopal%20S,%20Jang%20S,%20Duran%20G,%20et%20al.%20IL-11%20induces%20NLRP3%20inflammasome%20activation%20in%20monocytes%20and%20inflammatory%20cell%20migration%20to%20the%20central%20nervous%20system.%20Proc%20Natl%20Acad%20Sci%20USA.%202023;120:e2221007120." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Lin CC, Edelson BT. New insights into the role of IL-1β in experimental autoimmune encephalomyelitis and multiple sclerosis. J Immunol. 2017;198:4553–60.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1700263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5509030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28583987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20CC,%20Edelson%20BT.%20New%20insights%20into%20the%20role%20of%20IL-1%CE%B2%20in%20experimental%20autoimmune%20encephalomyelitis%20and%20multiple%20sclerosis.%20J%20Immunol.%202017;198:4553%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Paré A, Mailhot B, Lévesque SA, Lacroix S. Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF. Brain Behav Immun. 2017;62:1–8.
</cite> [<a href="https://doi.org/10.1016/j.bbi.2016.07.146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27432634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Par%C3%A9%20A,%20Mailhot%20B,%20L%C3%A9vesque%20SA,%20Lacroix%20S.%20Involvement%20of%20the%20IL-1%20system%20in%20experimental%20autoimmune%20encephalomyelitis%20and%20multiple%20sclerosis:%20Breaking%20the%20vicious%20cycle%20between%20IL-1%CE%B2%20and%20GM-CSF.%20Brain%20Behav%20Immun.%202017;62:1%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther. 2022;7:206.
</cite> [<a href="https://doi.org/10.1038/s41392-022-01070-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9247101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35773269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20M,%20Wang%20L,%20Wang%20M,%20Zhou%20S,%20Lu%20Y,%20Cui%20H,%20et%20al.%20Targeting%20fibrosis,%20mechanisms%20and%20cilinical%20trials.%20Signal%20Transduct%20Target%20Ther.%202022;7:206." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Liu Y, Xu X, Lei W, Hou Y, Zhang Y, Tang R, et al. The NLRP3 inflammasome in fibrosis and aging: the known unknowns. Ageing Res Rev. 2022;79:101638.
</cite> [<a href="https://doi.org/10.1016/j.arr.2022.101638" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35525426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Xu%20X,%20Lei%20W,%20Hou%20Y,%20Zhang%20Y,%20Tang%20R,%20et%20al.%20The%20NLRP3%20inflammasome%20in%20fibrosis%20and%20aging:%20the%20known%20unknowns.%20Ageing%20Res%20Rev.%202022;79:101638." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Babuta M, Morel C, de Carvalho Ribeiro M, Calenda C, Ortega-Ribera M, Thevkar Nagesh P, et al. Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis. Gut. 2024;73:1854–69.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2023-331447" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11458363/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38777573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Babuta%20M,%20Morel%20C,%20de%20Carvalho%20Ribeiro%20M,%20Calenda%20C,%20Ortega-Ribera%20M,%20Thevkar%20Nagesh%20P,%20et%20al.%20Neutrophil%20extracellular%20traps%20activate%20hepatic%20stellate%20cells%20and%20monocytes%20via%20NLRP3%20sensing%20in%20alcohol-induced%20acceleration%20of%20MASH%20fibrosis.%20Gut.%202024;73:1854%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Kaufmann B, Leszczynska A, Reca A, Booshehri LM, Onyuru J, Tan Z, et al. NLRP3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis. EMBO Rep. 2022;23:e54446.
</cite> [<a href="https://doi.org/10.15252/embr.202154446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9638850/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36194627/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaufmann%20B,%20Leszczynska%20A,%20Reca%20A,%20Booshehri%20LM,%20Onyuru%20J,%20Tan%20Z,%20et%20al.%20NLRP3%20activation%20in%20neutrophils%20induces%20lethal%20autoinflammation,%20liver%20inflammation,%20and%20fibrosis.%20EMBO%20Rep.%202022;23:e54446." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Han YC, Tang SQ, Liu YT, Li AM, Zhan M, Yang M, et al. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 2021;12:925.
</cite> [<a href="https://doi.org/10.1038/s41419-021-04184-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8502176/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34628484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han%20YC,%20Tang%20SQ,%20Liu%20YT,%20Li%20AM,%20Zhan%20M,%20Yang%20M,%20et%20al.%20AMPK%20agonist%20alleviate%20renal%20tubulointerstitial%20fibrosis%20via%20activating%20mitophagy%20in%20high%20fat%20and%20streptozotocin%20induced%20diabetic%20mice.%20Cell%20Death%20Dis.%202021;12:925." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Li J, Lin Q, Shao X, Li S, Zhu X, Wu J, et al. HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome. Cell Death Dis. 2023;14:200.
</cite> [<a href="https://doi.org/10.1038/s41419-023-05587-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10020151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36928344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Lin%20Q,%20Shao%20X,%20Li%20S,%20Zhu%20X,%20Wu%20J,%20et%20al.%20HIF1%CE%B1-BNIP3-mediated%20mitophagy%20protects%20against%20renal%20fibrosis%20by%20decreasing%20ROS%20and%20inhibiting%20activation%20of%20the%20NLRP3%20inflammasome.%20Cell%20Death%20Dis.%202023;14:200." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Wu M, Yang Z, Zhang C, Shi Y, Han W, Song S, et al. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Metabolism. 2021;118:154748.
</cite> [<a href="https://doi.org/10.1016/j.metabol.2021.154748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33675822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20M,%20Yang%20Z,%20Zhang%20C,%20Shi%20Y,%20Han%20W,%20Song%20S,%20et%20al.%20Inhibition%20of%20NLRP3%20inflammasome%20ameliorates%20podocyte%20damage%20by%20suppressing%20lipid%20accumulation%20in%20diabetic%20nephropathy.%20Metabolism.%202021;118:154748." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Sokolova M, Sjaastad I, Louwe MC, Alfsnes K, Aronsen JM, Zhang L, et al. NLRP3 inflammasome promotes myocardial remodeling during diet-induced obesity. Front Immunol. 2019;10:1621.
</cite> [<a href="https://doi.org/10.3389/fimmu.2019.01621" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6648799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31379826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sokolova%20M,%20Sjaastad%20I,%20Louwe%20MC,%20Alfsnes%20K,%20Aronsen%20JM,%20Zhang%20L,%20et%20al.%20NLRP3%20inflammasome%20promotes%20myocardial%20remodeling%20during%20diet-induced%20obesity.%20Front%20Immunol.%202019;10:1621." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Van Tin H, Rethi L, Higa S, Kao YH, Chen YJ. Spike protein of SARS-CoV-2 activates cardiac fibrogenesis through NLRP3 inflammasomes and NF-κB signaling. Cells. 2024;13:1331.</cite> [<a href="https://doi.org/10.3390/cells13161331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11353017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39195221/" class="usa-link">PubMed</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Wāng Y. Ambient fine particulate matter provokes multiple modalities of cell death via perturbation of subcellular structures. Environ Int. 2024;195:109193.
</cite> [<a href="https://doi.org/10.1016/j.envint.2024.109193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39721566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?W%C4%81ng%20Y.%20Ambient%20fine%20particulate%20matter%20provokes%20multiple%20modalities%20of%20cell%20death%20via%20perturbation%20of%20subcellular%20structures.%20Environ%20Int.%202024;195:109193." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Zhang CY, Ou AJ, Jin L, Yang NS, Deng P, Guan CX, et al. Cadmium exposure triggers alveolar epithelial cell pyroptosis by inducing mitochondrial oxidative stress and activating the cGAS-STING pathway. Cell Commun Signal. 2024;22:566.
</cite> [<a href="https://doi.org/10.1186/s12964-024-01946-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11590492/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39587603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20CY,%20Ou%20AJ,%20Jin%20L,%20Yang%20NS,%20Deng%20P,%20Guan%20CX,%20et%20al.%20Cadmium%20exposure%20triggers%20alveolar%20epithelial%20cell%20pyroptosis%20by%20inducing%20mitochondrial%20oxidative%20stress%20and%20activating%20the%20cGAS-STING%20pathway.%20Cell%20Commun%20Signal.%202024;22:566." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Kim SY, Park S, Cui R, Lee H, Choi H, Farh ME, et al. NXC736 attenuates radiation-induced lung fibrosis via regulating NLRP3/IL-1β signaling pathway. Int J Mol Sci. 2023;24:16265.</cite> [<a href="https://doi.org/10.3390/ijms242216265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10671169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38003456/" class="usa-link">PubMed</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Zhang J, Zhang J, Yao Z, Shao W, Song Y, Tang W, et al. GAMG ameliorates silica-induced pulmonary inflammation and fibrosis via the regulation of EMT and NLRP3/TGF-β1/Smad signaling pathway. Ecotoxicol Environ Saf. 2024;285:117124.
</cite> [<a href="https://doi.org/10.1016/j.ecoenv.2024.117124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39342756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20J,%20Zhang%20J,%20Yao%20Z,%20Shao%20W,%20Song%20Y,%20Tang%20W,%20et%20al.%20GAMG%20ameliorates%20silica-induced%20pulmonary%20inflammation%20and%20fibrosis%20via%20the%20regulation%20of%20EMT%20and%20NLRP3/TGF-%CE%B21/Smad%20signaling%20pathway.%20Ecotoxicol%20Environ%20Saf.%202024;285:117124." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Shao W, Zhang J, Yao Z, Zhao P, Li B, Tang W, et al. Cannabidiol suppresses silica-induced pulmonary inflammation and fibrosis through regulating NLRP3/TGF-β1/Smad2/3 pathway. Int Immunopharmacol. 2024;142:113088.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2024.113088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39244899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shao%20W,%20Zhang%20J,%20Yao%20Z,%20Zhao%20P,%20Li%20B,%20Tang%20W,%20et%20al.%20Cannabidiol%20suppresses%20silica-induced%20pulmonary%20inflammation%20and%20fibrosis%20through%20regulating%20NLRP3/TGF-%CE%B21/Smad2/3%20pathway.%20Int%20Immunopharmacol.%202024;142:113088." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Schwartz SM. Epidemiology of cancer. Clin Chem. 2024;70:140–9.
</cite> [<a href="https://doi.org/10.1093/clinchem/hvad202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38175589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schwartz%20SM.%20Epidemiology%20of%20cancer.%20Clin%20Chem.%202024;70:140%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Shadab A, Mahjoor M, Abbasi-Kolli M, Afkhami H, Moeinian P, Safdarian AR. Divergent functions of NLRP3 inflammasomes in cancer: a review. Cell Commun Signal. 2023;21:232.
</cite> [<a href="https://doi.org/10.1186/s12964-023-01235-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10503066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37715239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shadab%20A,%20Mahjoor%20M,%20Abbasi-Kolli%20M,%20Afkhami%20H,%20Moeinian%20P,%20Safdarian%20AR.%20Divergent%20functions%20of%20NLRP3%20inflammasomes%20in%20cancer:%20a%20review.%20Cell%20Commun%20Signal.%202023;21:232." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Tengesdal IW, Dinarello CA, Marchetti C. NLRP3 and cancer: pathogenesis and therapeutic opportunities. Pharm Ther. 2023;251:108545.</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2023.108545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10710902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37866732/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tengesdal%20IW,%20Dinarello%20CA,%20Marchetti%20C.%20NLRP3%20and%20cancer:%20pathogenesis%20and%20therapeutic%20opportunities.%20Pharm%20Ther.%202023;251:108545." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Hamarsheh S, Zeiser R. NLRP3 inflammasome activation in cancer: a double-edged sword. Front Immunol. 2020;11:1444.
</cite> [<a href="https://doi.org/10.3389/fimmu.2020.01444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7360837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32733479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hamarsheh%20S,%20Zeiser%20R.%20NLRP3%20inflammasome%20activation%20in%20cancer:%20a%20double-edged%20sword.%20Front%20Immunol.%202020;11:1444." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Guan X, Liu R, Wang B, Xiong R, Cui L, Liao Y, et al. Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer. Clin Transl Med. 2024;14:e1692.
</cite> [<a href="https://doi.org/10.1002/ctm2.1692" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11131357/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38804602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guan%20X,%20Liu%20R,%20Wang%20B,%20Xiong%20R,%20Cui%20L,%20Liao%20Y,%20et%20al.%20Inhibition%20of%20HDAC2%20sensitises%20antitumour%20therapy%20by%20promoting%20NLRP3/GSDMD-mediated%20pyroptosis%20in%20colorectal%20cancer.%20Clin%20Transl%20Med.%202024;14:e1692." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Jang JH, Kim DH, Lim JM, Lee JW, Jeong SJ, Kim KP, et al. Breast cancer cell-derived soluble CD44 promotes tumor progression by triggering macrophage IL1β production. Cancer Res. 2020;80:1342–56.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-19-2288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31969374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jang%20JH,%20Kim%20DH,%20Lim%20JM,%20Lee%20JW,%20Jeong%20SJ,%20Kim%20KP,%20et%20al.%20Breast%20cancer%20cell-derived%20soluble%20CD44%20promotes%20tumor%20progression%20by%20triggering%20macrophage%20IL1%CE%B2%20production.%20Cancer%20Res.%202020;80:1342%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Faria SS, Costantini S, de Lima VCC, de Andrade VP, Rialland M, Cedric R, et al. NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer. J Biomed Sci. 2021;28:26.
</cite> [<a href="https://doi.org/10.1186/s12929-021-00724-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8040227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33840390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Faria%20SS,%20Costantini%20S,%20de%20Lima%20VCC,%20de%20Andrade%20VP,%20Rialland%20M,%20Cedric%20R,%20et%20al.%20NLRP3%20inflammasome-mediated%20cytokine%20production%20and%20pyroptosis%20cell%20death%20in%20breast%20cancer.%20J%20Biomed%20Sci.%202021;28:26." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Zheng Q, Yao D, Cai Y, Zhou T. NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway. Biosci Rep. 2020;40:BSR20200730.</cite> [<a href="https://doi.org/10.1042/BSR20200730" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7335831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32578856/" class="usa-link">PubMed</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Wang Y, Kong H, Zeng X, Liu W, Wang Z, Yan X, et al. Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells. Oncol Rep. 2016;35:2053–64.
</cite> [<a href="https://doi.org/10.3892/or.2016.4569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26782741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Kong%20H,%20Zeng%20X,%20Liu%20W,%20Wang%20Z,%20Yan%20X,%20et%20al.%20Activation%20of%20NLRP3%20inflammasome%20enhances%20the%20proliferation%20and%20migration%20of%20A549%20lung%20cancer%20cells.%20Oncol%20Rep.%202016;35:2053%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Malireddi RKS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:406.
</cite> [<a href="https://doi.org/10.3389/fcimb.2019.00406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6902032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31850239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Malireddi%20RKS,%20Kesavardhana%20S,%20Kanneganti%20TD.%20ZBP1%20and%20TAK1:%20master%20regulators%20of%20NLRP3%20inflammasome/pyroptosis,%20apoptosis,%20and%20necroptosis%20(PAN-optosis).%20Front%20Cell%20Infect%20Microbiol.%202019;9:406." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Chen W, Gullett JM, Tweedell RE, Kanneganti TD. Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease. Eur J Immunol. 2023;53:e2250235.
</cite> [<a href="https://doi.org/10.1002/eji.202250235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10423303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36782083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20W,%20Gullett%20JM,%20Tweedell%20RE,%20Kanneganti%20TD.%20Innate%20immune%20inflammatory%20cell%20death:%20PANoptosis%20and%20PANoptosomes%20in%20host%20defense%20and%20disease.%20Eur%20J%20Immunol.%202023;53:e2250235." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Gurung P, Anand PK, Malireddi RK, Vande Walle L, Van Opdenbosch N, Dillon CP, et al. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. J Immunol. 2014;192:1835–46.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1302839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3933570/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24453255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gurung%20P,%20Anand%20PK,%20Malireddi%20RK,%20Vande%20Walle%20L,%20Van%20Opdenbosch%20N,%20Dillon%20CP,%20et%20al.%20FADD%20and%20caspase-8%20mediate%20priming%20and%20activation%20of%20the%20canonical%20and%20noncanonical%20Nlrp3%20inflammasomes.%20J%20Immunol.%202014;192:1835%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Newton K, Wickliffe KE, Maltzman A, Dugger DL, Reja R, Zhang Y, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575:679–82.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1752-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31723262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Newton%20K,%20Wickliffe%20KE,%20Maltzman%20A,%20Dugger%20DL,%20Reja%20R,%20Zhang%20Y,%20et%20al.%20Activity%20of%20caspase-8%20determines%20plasticity%20between%20cell%20death%20pathways.%20Nature.%202019;575:679%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Man SM, Karki R, Malireddi RK, Neale G, Vogel P, Yamamoto M, et al. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol. 2015;16:467–75.
</cite> [<a href="https://doi.org/10.1038/ni.3118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4406811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25774715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Man%20SM,%20Karki%20R,%20Malireddi%20RK,%20Neale%20G,%20Vogel%20P,%20Yamamoto%20M,%20et%20al.%20The%20transcription%20factor%20IRF1%20and%20guanylate-binding%20proteins%20target%20activation%20of%20the%20AIM2%20inflammasome%20by%20Francisella%20infection.%20Nat%20Immunol.%202015;16:467%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Xiang Q, Geng ZX, Yi X, Wei X, Zhu XH, Jiang DS. PANoptosis: a novel target for cardiovascular diseases. Trends Pharmacol Sci. 2024;45:739–56.
</cite> [<a href="https://doi.org/10.1016/j.tips.2024.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39003157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiang%20Q,%20Geng%20ZX,%20Yi%20X,%20Wei%20X,%20Zhu%20XH,%20Jiang%20DS.%20PANoptosis:%20a%20novel%20target%20for%20cardiovascular%20diseases.%20Trends%20Pharmacol%20Sci.%202024;45:739%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Pandeya A, Kanneganti TD. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes. Trends Mol Med. 2024;30:74–88.
</cite> [<a href="https://doi.org/10.1016/j.molmed.2023.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10842719/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37977994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pandeya%20A,%20Kanneganti%20TD.%20Therapeutic%20potential%20of%20PANoptosis:%20innate%20sensors,%20inflammasomes,%20and%20RIPKs%20in%20PANoptosomes.%20Trends%20Mol%20Med.%202024;30:74%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Sundaram B, Pandian N, Kim HJ, Abdelaal HM, Mall R, Indari O, et al. NLRC5 senses NAD(+) depletion, forming a PANoptosome and driving PANoptosis and inflammation. Cell. 2024;187:4061–4077.e4017.
</cite> [<a href="https://doi.org/10.1016/j.cell.2024.05.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11283362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38878777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sundaram%20B,%20Pandian%20N,%20Kim%20HJ,%20Abdelaal%20HM,%20Mall%20R,%20Indari%20O,%20et%20al.%20NLRC5%20senses%20NAD(+)%20depletion,%20forming%20a%20PANoptosome%20and%20driving%20PANoptosis%20and%20inflammation.%20Cell.%202024;187:4061%E2%80%934077.e4017." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:237.
</cite> [<a href="https://doi.org/10.3389/fcimb.2020.00237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7274033/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32547960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Christgen%20S,%20Zheng%20M,%20Kesavardhana%20S,%20Karki%20R,%20Malireddi%20RKS,%20Banoth%20B,%20et%20al.%20Identification%20of%20the%20PANoptosome:%20a%20molecular%20platform%20triggering%20pyroptosis,%20apoptosis,%20and%20necroptosis%20(PANoptosis).%20Front%20Cell%20Infect%20Microbiol.%202020;10:237." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016;1:aag2045.</cite> [<a href="https://doi.org/10.1126/sciimmunol.aag2045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5131924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27917412/" class="usa-link">PubMed</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Fritsch M, Günther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019;575:683–7.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1770-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31748744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fritsch%20M,%20G%C3%BCnther%20SD,%20Schwarzer%20R,%20Albert%20MC,%20Schorn%20F,%20Werthenbach%20JP,%20et%20al.%20Caspase-8%20is%20the%20molecular%20switch%20for%20apoptosis,%20necroptosis%20and%20pyroptosis.%20Nature.%202019;575:683%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Zheng M, Karki R, Vogel P, Kanneganti TD. Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense. Cell. 2020;181:674–687.e613.
</cite> [<a href="https://doi.org/10.1016/j.cell.2020.03.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7425208/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32298652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20M,%20Karki%20R,%20Vogel%20P,%20Kanneganti%20TD.%20Caspase-6%20Is%20a%20Key%20Regulator%20of%20Innate%20Immunity,%20Inflammasome%20Activation,%20and%20Host%20Defense.%20Cell.%202020;181:674%E2%80%93687.e613." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Qi L, Wang L, Jin M, Jiang M, Li L, Li Y. Caspase-6 is a key regulator of cross-talk signal way in PANoptosis in cancer. Immunology. 2023;169:245–59.
</cite> [<a href="https://doi.org/10.1111/imm.13633" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36814103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qi%20L,%20Wang%20L,%20Jin%20M,%20Jiang%20M,%20Li%20L,%20Li%20Y.%20Caspase-6%20is%20a%20key%20regulator%20of%20cross-talk%20signal%20way%20in%20PANoptosis%20in%20cancer.%20Immunology.%202023;169:245%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z, et al. Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis. 2023;14:851.
</cite> [<a href="https://doi.org/10.1038/s41419-023-06370-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10739961/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38129399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20L,%20Zhu%20Y,%20Zhang%20L,%20Guo%20L,%20Wang%20X,%20Pan%20Z,%20et%20al.%20Mechanisms%20of%20PANoptosis%20and%20relevant%20small-molecule%20compounds%20for%20fighting%20diseases.%20Cell%20Death%20Dis.%202023;14:851." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Mangan MS, Latz E. TAK1ng control: TAK1 restrains NLRP3 activation. J Exp Med. 2018;215:1007–8.
</cite> [<a href="https://doi.org/10.1084/jem.20180282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5881475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29507056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mangan%20MS,%20Latz%20E.%20TAK1ng%20control:%20TAK1%20restrains%20NLRP3%20activation.%20J%20Exp%20Med.%202018;215:1007%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Sharma BR, Karki R, Rajesh Y, Kanneganti TD. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis). J Biol Chem. 2023;299:105141.
</cite> [<a href="https://doi.org/10.1016/j.jbc.2023.105141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10494469/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37557956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sharma%20BR,%20Karki%20R,%20Rajesh%20Y,%20Kanneganti%20TD.%20Immune%20regulator%20IRF1%20contributes%20to%20ZBP1-,%20AIM2-,%20RIPK1-,%20and%20NLRP12-PANoptosome%20activation%20and%20inflammatory%20cell%20death%20(PANoptosis).%20J%20Biol%20Chem.%202023;299:105141." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Sundaram B, Pandian N, Mall R, Wang Y, Sarkar R, Kim HJ, et al. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell. 2023;186:2783–2801.e2720.
</cite> [<a href="https://doi.org/10.1016/j.cell.2023.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10330523/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37267949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sundaram%20B,%20Pandian%20N,%20Mall%20R,%20Wang%20Y,%20Sarkar%20R,%20Kim%20HJ,%20et%20al.%20NLRP12-PANoptosome%20activates%20PANoptosis%20and%20pathology%20in%20response%20to%20heme%20and%20PAMPs.%20Cell.%202023;186:2783%E2%80%932801.e2720." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D, Massey NL, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15:556–9.
</cite> [<a href="https://doi.org/10.1038/s41589-019-0277-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31086327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Coll%20RC,%20Hill%20JR,%20Day%20CJ,%20Zamoshnikova%20A,%20Boucher%20D,%20Massey%20NL,%20et%20al.%20MCC950%20directly%20targets%20the%20NLRP3%20ATP-hydrolysis%20motif%20for%20inflammasome%20inhibition.%20Nat%20Chem%20Biol.%202019;15:556%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Perregaux DG, McNiff P, Laliberte R, Hawryluk N, Peurano H, Stam E, et al. Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors. J Pharm Exp Ther. 2001;299:187–97.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11561079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perregaux%20DG,%20McNiff%20P,%20Laliberte%20R,%20Hawryluk%20N,%20Peurano%20H,%20Stam%20E,%20et%20al.%20Identification%20and%20characterization%20of%20a%20novel%20class%20of%20interleukin-1%20post-translational%20processing%20inhibitors.%20J%20Pharm%20Exp%20Ther.%202001;299:187%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Corcoran SE, Halai R, Cooper MA. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950. Pharm Rev. 2021;73:968–1000.
</cite> [<a href="https://doi.org/10.1124/pharmrev.120.000171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34117094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corcoran%20SE,%20Halai%20R,%20Cooper%20MA.%20Pharmacological%20Inhibition%20of%20the%20Nod-Like%20Receptor%20Family%20Pyrin%20Domain%20Containing%203%20Inflammasome%20with%20MCC950.%20Pharm%20Rev.%202021;73:968%E2%80%931000." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Parmar DV, Kansagra KA, Momin T, Patel HB, Jansari GA, Bhavsar J, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First-in-Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose). Clin Pharm Drug Dev. 2023;12:202–11.</cite> [<a href="https://doi.org/10.1002/cpdd.1162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10087697/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36065092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parmar%20DV,%20Kansagra%20KA,%20Momin%20T,%20Patel%20HB,%20Jansari%20GA,%20Bhavsar%20J,%20et%20al.%20Safety,%20Tolerability,%20Pharmacokinetics,%20and%20Pharmacodynamics%20of%20the%20Oral%20NLRP3%20Inflammasome%20Inhibitor%20ZYIL1:%20First-in-Human%20Phase%201%20Studies%20(Single%20Ascending%20Dose%20and%20Multiple%20Ascending%20Dose).%20Clin%20Pharm%20Drug%20Dev.%202023;12:202%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Hissaria P, Kansagra K, Patel H, Momin T, Ghoghari A, Patel H, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of ZY-IL1 in three patients with cryopyrin-associated periodic syndromes. Clin Pharmacol Drug Dev. 2024;13:152–9.
</cite> [<a href="https://doi.org/10.1002/cpdd.1318" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37577847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hissaria%20P,%20Kansagra%20K,%20Patel%20H,%20Momin%20T,%20Ghoghari%20A,%20Patel%20H,%20et%20al.%20Safety,%20tolerability,%20pharmacokinetics,%20and%20pharmacodynamics%20of%20ZY-IL1%20in%20three%20patients%20with%20cryopyrin-associated%20periodic%20syndromes.%20Clin%20Pharmacol%20Drug%20Dev.%202024;13:152%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Gatlik E, Mehes B, Voltz E, Sommer U, Tritto E, Lestini G, et al. First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor. Clin Transl Sci. 2024;17:e13789.
</cite> [<a href="https://doi.org/10.1111/cts.13789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11101992/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38761014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gatlik%20E,%20Mehes%20B,%20Voltz%20E,%20Sommer%20U,%20Tritto%20E,%20Lestini%20G,%20et%20al.%20First-in-human%20safety,%20tolerability,%20and%20pharmacokinetic%20results%20of%20DFV890,%20an%20oral%20low-molecular-weight%20NLRP3%20inhibitor.%20Clin%20Transl%20Sci.%202024;17:e13789." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A, et al. DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function. Infection. 2023;51:641–54.
</cite> [<a href="https://doi.org/10.1007/s15010-022-01904-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9473473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36104613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Madurka%20I,%20Vishnevsky%20A,%20Soriano%20JB,%20Gans%20SJ,%20Ore%20DJS,%20Rendon%20A,%20et%20al.%20DFV890:%20a%20new%20oral%20NLRP3%20inhibitor-tested%20in%20an%20early%20phase%202a%20randomised%20clinical%20trial%20in%20patients%20with%20COVID-19%20pneumonia%20and%20impaired%20respiratory%20function.%20Infection.%202023;51:641%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Shen DM, Byth KF, Bertheloot D, Braams S, Bradley S, Dean D, et al. Discovery of DFV890, a potent sulfonimidamide-containing NLRP3 inflammasome inhibitor. J Med Chem. 2025;68:5529–50.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.4c02759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40036600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20DM,%20Byth%20KF,%20Bertheloot%20D,%20Braams%20S,%20Bradley%20S,%20Dean%20D,%20et%20al.%20Discovery%20of%20DFV890,%20a%20potent%20sulfonimidamide-containing%20NLRP3%20inflammasome%20inhibitor.%20J%20Med%20Chem.%202025;68:5529%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Schwaid AG, Spencer KB. Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space. J Med Chem. 2021;64:101–22.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.0c01307" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33351619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schwaid%20AG,%20Spencer%20KB.%20Strategies%20for%20targeting%20the%20NLRP3%20inflammasome%20in%20the%20clinical%20and%20preclinical%20space.%20J%20Med%20Chem.%202021;64:101%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2024;23:43–66.
</cite> [<a href="https://doi.org/10.1038/s41573-023-00822-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38030687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vande%20Walle%20L,%20Lamkanfi%20M.%20Drugging%20the%20NLRP3%20inflammasome:%20from%20signalling%20mechanisms%20to%20therapeutic%20targets.%20Nat%20Rev%20Drug%20Discov.%202024;23:43%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Klughammer B, Piali L, Nica A, Nagel S, Bailey L, Jochum C, et al. A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis. Clin Transl Med. 2023;13:e1471.
</cite> [<a href="https://doi.org/10.1002/ctm2.1471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10644327/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37962000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klughammer%20B,%20Piali%20L,%20Nica%20A,%20Nagel%20S,%20Bailey%20L,%20Jochum%20C,%20et%20al.%20A%20randomized,%20double-blind%20phase%201b%20study%20evaluating%20the%20safety,%20tolerability,%20pharmacokinetics%20and%20pharmacodynamics%20of%20the%20NLRP3%20inhibitor%20selnoflast%20in%20patients%20with%20moderate%20to%20severe%20active%20ulcerative%20colitis.%20Clin%20Transl%20Med.%202023;13:e1471." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T, et al. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proc Natl Acad Sci USA. 2018;115:E1530–e1539.
</cite> [<a href="https://doi.org/10.1073/pnas.1716095115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5816172/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29378952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marchetti%20C,%20Swartzwelter%20B,%20Gamboni%20F,%20Neff%20CP,%20Richter%20K,%20Azam%20T,%20et%20al.%20OLT1177,%20a%20%CE%B2-sulfonyl%20nitrile%20compound,%20safe%20in%20humans,%20inhibits%20the%20NLRP3%20inflammasome%20and%20reverses%20the%20metabolic%20cost%20of%20inflammation.%20Proc%20Natl%20Acad%20Sci%20USA.%202018;115:E1530%E2%80%93e1539." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Blevins HM, Xu Y, Biby S, Zhang S. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases. Front Aging Neurosci. 2022;14:879021.
</cite> [<a href="https://doi.org/10.3389/fnagi.2022.879021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9226403/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35754962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Blevins%20HM,%20Xu%20Y,%20Biby%20S,%20Zhang%20S.%20The%20NLRP3%20inflammasome%20pathway:%20a%20review%20of%20mechanisms%20and%20inhibitors%20for%20the%20treatment%20of%20inflammatory%20diseases.%20Front%20Aging%20Neurosci.%202022;14:879021." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Klück V, Jansen T, Janssen M, Comarniceanu A, Efdé M, Tengesdal IW, et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2020;2:e270–e280.
</cite> [<a href="https://doi.org/10.1016/s2665-9913(20)30065-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7523621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33005902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kl%C3%BCck%20V,%20Jansen%20T,%20Janssen%20M,%20Comarniceanu%20A,%20Efd%C3%A9%20M,%20Tengesdal%20IW,%20et%20al.%20Dapansutrile,%20an%20oral%20selective%20NLRP3%20inflammasome%20inhibitor,%20for%20treatment%20of%20gout%20flares:%20an%20open-label,%20dose-adaptive,%20proof-of-concept,%20phase%202a%20trial.%20Lancet%20Rheumatol.%202020;2:e270%E2%80%93e280." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Tengesdal IW, Li S, Powers NE, May M, Neff CP, Joosten LAB, et al. Activation of host-NLRP3 inflammasome in myeloid cells dictates response to anti-PD-1 Therapy in Metastatic Breast Cancers. Pharmaceuticals. 2022;15:574.</cite> [<a href="https://doi.org/10.3390/ph15050574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9144656/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35631400/" class="usa-link">PubMed</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Hamon Y, Luciani MF, Becq F, Verrier B, Rubartelli A, Chimini G. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood. 1997;90:2911–5.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9376570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hamon%20Y,%20Luciani%20MF,%20Becq%20F,%20Verrier%20B,%20Rubartelli%20A,%20Chimini%20G.%20Interleukin-1beta%20secretion%20is%20impaired%20by%20inhibitors%20of%20the%20Atp%20binding%20cassette%20transporter,%20ABC1.%20Blood.%201997;90:2911%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, Deshayes K, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol. 2009;187:61–70.
</cite> [<a href="https://doi.org/10.1083/jcb.200903124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2762099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19805629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lamkanfi%20M,%20Mueller%20JL,%20Vitari%20AC,%20Misaghi%20S,%20Fedorova%20A,%20Deshayes%20K,%20et%20al.%20Glyburide%20inhibits%20the%20Cryopyrin/Nalp3%20inflammasome.%20J%20Cell%20Biol.%202009;187:61%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Jiang Y, He L, Green J, Blevins H, Guo C, Patel SH, et al. Discovery of second-generation NLRP3 inflammasome inhibitors: design, synthesis, and biological characterization. J Med Chem. 2019;62:9718–31.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.9b01155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6856409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31626545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20Y,%20He%20L,%20Green%20J,%20Blevins%20H,%20Guo%20C,%20Patel%20SH,%20et%20al.%20Discovery%20of%20second-generation%20NLRP3%20inflammasome%20inhibitors:%20design,%20synthesis,%20and%20biological%20characterization.%20J%20Med%20Chem.%202019;62:9718%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Guo C, Fulp JW, Jiang Y, Li X, Chojnacki JE, Wu J, et al. Development and characterization of a hydroxyl-sulfonamide analogue, 5-chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a novel NLRP3 inflammasome inhibitor for potential treatment of multiple sclerosis. ACS Chem Neurosci. 2017;8:2194–201.</cite> [<a href="https://doi.org/10.1021/acschemneuro.7b00124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5672903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28653829/" class="usa-link">PubMed</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Sun X, Duan J, Gong C, Feng Y, Hu J, Gu R, et al. Colchicine ameliorates dilated cardiomyopathy via SIRT2-mediated suppression of NLRP3 inflammasome activation. J Am Heart Assoc. 2022;11:e025266.
</cite> [<a href="https://doi.org/10.1161/JAHA.122.025266" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9333380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35766262/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20X,%20Duan%20J,%20Gong%20C,%20Feng%20Y,%20Hu%20J,%20Gu%20R,%20et%20al.%20Colchicine%20ameliorates%20dilated%20cardiomyopathy%20via%20SIRT2-mediated%20suppression%20of%20NLRP3%20inflammasome%20activation.%20J%20Am%20Heart%20Assoc.%202022;11:e025266." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>He J, Deng Y, Ren L, Jin Z, Yang J, Yao F, et al. Isoliquiritigenin from licorice flavonoids attenuates NLRP3-mediated pyroptosis by SIRT6 in vascular endothelial cells. J Ethnopharmacol. 2023;303:115952.
</cite> [<a href="https://doi.org/10.1016/j.jep.2022.115952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36442759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He%20J,%20Deng%20Y,%20Ren%20L,%20Jin%20Z,%20Yang%20J,%20Yao%20F,%20et%20al.%20Isoliquiritigenin%20from%20licorice%20flavonoids%20attenuates%20NLRP3-mediated%20pyroptosis%20by%20SIRT6%20in%20vascular%20endothelial%20cells.%20J%20Ethnopharmacol.%202023;303:115952." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Li M, Ma L, Lv J, Zheng Z, Lu W, Yin X, et al. Design, synthesis, and biological evaluation of oridonin derivatives as novel NLRP3 inflammasome inhibitors for the treatment of acute lung injury. Eur J Med Chem. 2024;277:116760.
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2024.116760" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39197252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20M,%20Ma%20L,%20Lv%20J,%20Zheng%20Z,%20Lu%20W,%20Yin%20X,%20et%20al.%20Design,%20synthesis,%20and%20biological%20evaluation%20of%20oridonin%20derivatives%20as%20novel%20NLRP3%20inflammasome%20inhibitors%20for%20the%20treatment%20of%20acute%20lung%20injury.%20Eur%20J%20Med%20Chem.%202024;277:116760." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>El-Sayed S, Freeman S, Bryce RA. A Selective Review and Virtual Screening Analysis of Natural Product Inhibitors of the NLRP3 Inflammasome. Molecules. 2022;27:6213.</cite> [<a href="https://doi.org/10.3390/molecules27196213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9573361/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36234744/" class="usa-link">PubMed</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Oh S, Lee J, Oh J, Yu G, Ryu H, Kim D, et al. Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis. Cell Mol Immunol. 2023;20:1513–26.
</cite> [<a href="https://doi.org/10.1038/s41423-023-01107-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10687226/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38008850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oh%20S,%20Lee%20J,%20Oh%20J,%20Yu%20G,%20Ryu%20H,%20Kim%20D,%20et%20al.%20Integrated%20NLRP3,%20AIM2,%20NLRC4,%20Pyrin%20inflammasome%20activation%20and%20assembly%20drive%20PANoptosis.%20Cell%20Mol%20Immunol.%202023;20:1513%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Sun W, Li P, Wang M, Xu Y, Shen D, Zhang X, et al. Molecular characterization of PANoptosis-related genes with features of immune dysregulation in systemic lupus erythematosus. Clin Immunol. 2023;253:109660.
</cite> [<a href="https://doi.org/10.1016/j.clim.2023.109660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37295541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20W,%20Li%20P,%20Wang%20M,%20Xu%20Y,%20Shen%20D,%20Zhang%20X,%20et%20al.%20Molecular%20characterization%20of%20PANoptosis-related%20genes%20with%20features%20of%20immune%20dysregulation%20in%20systemic%20lupus%20erythematosus.%20Clin%20Immunol.%202023;253:109660." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Tong J, Lan XT, Zhang Z, Liu Y, Sun DY, Wang XJ, et al. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharm Sin. 2023;44:1014–28.</cite> [<a href="https://doi.org/10.1038/s41401-022-01010-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10104837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36323829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tong%20J,%20Lan%20XT,%20Zhang%20Z,%20Liu%20Y,%20Sun%20DY,%20Wang%20XJ,%20et%20al.%20Ferroptosis%20inhibitor%20liproxstatin-1%20alleviates%20metabolic%20dysfunction-associated%20fatty%20liver%20disease%20in%20mice:%20potential%20involvement%20of%20PANoptosis.%20Acta%20Pharm%20Sin.%202023;44:1014%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Shen J, San W, Zheng Y, Zhang S, Cao D, Chen Y, et al. Different types of cell death in diabetic endothelial dysfunction. Biomed Pharmacother. 2023;168:115802.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.115802" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37918258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shen%20J,%20San%20W,%20Zheng%20Y,%20Zhang%20S,%20Cao%20D,%20Chen%20Y,%20et%20al.%20Different%20types%20of%20cell%20death%20in%20diabetic%20endothelial%20dysfunction.%20Biomed%20Pharmacother.%202023;168:115802." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Gao L, Shay C, Teng Y. Cell death shapes cancer immunity: spotlighting PANoptosis. J Exp Clin Cancer Res. 2024;43:168.
</cite> [<a href="https://doi.org/10.1186/s13046-024-03089-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11179218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38877579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20L,%20Shay%20C,%20Teng%20Y.%20Cell%20death%20shapes%20cancer%20immunity:%20spotlighting%20PANoptosis.%20J%20Exp%20Clin%20Cancer%20Res.%202024;43:168." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cell Death Discovery are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41420-025-02689-1"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41420_2025_Article_2689.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12365032/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12365032/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365032%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365032/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12365032/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12365032/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830103/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12365032/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830103/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12365032/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12365032/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ocucgQ9ue0g0Hpd7mtslo8yKF3Vwr7Jso4LdD3ANh0m2K0ey4ImTU6HpxTUmr12T">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
